acebutolol has been researched along with Hypertension in 275 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "40 patients with essential hypertension were studied to ascertain the effects of a selective b1-blocker (acebutolol, 400 mg/day) on serum lipids, antioxidant status, antioxidant enzyme activity in red blood cells (RBC), and membrane fatty acids composition." | 9.10 | Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. ( Belleville, JL; Bouchenak, M; Cherrad, A; Krouf, D; Mohammedi, B; Prost, JL, 2003) |
| "The main purpose of our study was to analyse efficacy and safety of acebutolol (Sectral) in the treatment of hypertension in pregnancy." | 9.10 | [Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents]. ( Kriska, M; Letkovicová, M; Mlyncek, M; Sirotiaková, J, 2002) |
| "The antihypertensive efficacy of single-drug therapy with nifedipine (N), prazosin (P), or acebutolol (A) and the influence of these agents on coronary risk factors including hypoglycemia, hyperuricemia, and hyperlipidemia, were studied in adolescents with hypertension." | 9.07 | [Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents]. ( Cichocka, E; Januszewicz, P; Wyszynska, T, 1993) |
| "The efficacy of the calcium channel blocker nitrendipine alone and in combination with the beta blocking agent acebutolol or hydrochlorothiazide was tested in 34 patients with moderate essential hypertension." | 9.06 | [Therapy of moderate hypertension with the calcium antagonist nitrendipine in combination with beta receptor blocker or diuretic]. ( Kolloch, R; Müller, HM; Overlack, A; Stumpe, KO, 1990) |
| "The efficacy, tolerance and effect on serum lipids of acebutolol were compared with those of atenolol over a 6-month period in a large group of patients with mild arterial hypertension." | 9.06 | Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension. ( De Backer, G, 1988) |
| "In a randomised, crossover study of patients with moderate to severe essential hypertension, the effects of the calcium entry antagonist nifedipine and the beta-receptor blocking drug acebutolol were studied on their own, and in combination." | 9.06 | Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension. ( MacGregor, GA; Markandu, ND; Shore, AC; Singer, DR, 1987) |
| "Acebutolol, a beta-1 selective beta blocker with intrinsic sympathomimetic activity has been shown to be an effective agent in chronic angina pectoris therapy, with twice or three times daily dosing." | 9.06 | Low-dose acebutolol given once daily in the treatment of chronic angina pectoris. ( Piña, IL; Smith, EV; Weidler, DJ, 1988) |
| "A double-blind multicenter study compared oral acebutolol (n = 182) with hydrochlorothiazide (n = 178) in the treatment of mild to moderate essential hypertension (diastolic blood pressure 95 to 114 mm Hg)." | 9.06 | Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation. ( Singh, BN; Thoden, WR; Wahl, J, 1986) |
| "The effects of acebutolol (with intrinsic sympathomimetic activity (ISA] and metoprolol (without ISA) on arm blood pressure, ankle systolic blood pressure, claudication distances (CD) and maximal walking distances (MWD) were compared in patients with essential hypertension and intermittent claudication." | 9.06 | The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication. ( Jelnes, R; Svendsen, TL; Tønnesen, KH, 1986) |
| "A double-blind, parallel group comparison study was carried out in 20 diabetic patients with mild to moderate hypertension to assess the effectiveness and tolerance of acebutolol compared with placebo." | 9.06 | Acebutolol in the treatment of diabetic patients with hypertension. ( Fraser, DM; Nimmo, GR; Poloniecki, JD, 1986) |
| "32 patients (13 women and 19 men) with slight to severe hypertension were treated during an open medium term study with acebutolol, a beta-antagonist which is cardioselective and at the same time has an intrinsic sympatheticomimetic effect." | 9.05 | [Acebutolol: experience with its use in ambulatory management of arterial hypertension]. ( Adamo, M; Battaglia, A, 1983) |
| "5 mg of slow-release (sr) clonidine, 800 mg of acebutolol, and of both drugs combined on blood pressure and the water-salt balance were compared in 10 patients with essential hypertension." | 9.05 | Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance. ( Cornette, M; Degoulet, P; Fermé, I; Ménard, J; Plouin, PF, 1983) |
| "One thousand four hundred and two patients with essential hypertension were treated by their general practitioners for 3 months with one tablet daily consisting of 200 mg acebutolol plus 12." | 9.05 | Treatment of essential hypertension with beta-blocker plus diuretic: a study of 1402 patients treated by general practitioners with acebutolol 200 mg combined with hydrochlorothiazide 12.5 mg ('Secadrex') once daily for 3 months. ( Baker, PG; McGowan, GK, 1984) |
| "The antihypertensive efficacy and the acceptability of nifedipine (NI, Adalat) and the usefulness of its combination with a beta 1-selective blocking drug, acebutolol (AC), were studied in a placebo controlled trial on 15 patients with moderate hypertension." | 9.05 | Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability. ( de Divitiis, O; Di Somma, S; Fazio, S; Galderisi, M; Liguori, V; Petitto, M; Santomauro, M; Villari, B, 1984) |
| "The efficacy and acceptability of a single half-tablet daily of a fixed combination of 400 mg acebutolol and 25 mg hydrochlorothiazide was assessed in a study of 35 patients suffering from mild to moderate essential hypertension." | 9.05 | The efficacy and acceptability of the combination of acebutolol and hydrochlorothiazide in the treatment of essential hypertension. ( Sugeng, I; Suryaatmaja, M; Sutandar, H; Utama, H, 1984) |
| "A double-blind, crossover comparison of once-daily acebutolol (400 mg) and once-daily atenolol (100 mg) was carried out in 33 patients with mild to moderate essential hypertension." | 9.05 | Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension. ( Brocklehurst, JC; Turner, AS, 1983) |
| "The effect of acebutolol (Sectral) was compared with that of placebo in 30 patients with mild to moderate hypertension who were receiving a thiazide diuretic." | 9.05 | Acebutolol in mild to moderate hypertension: a double-blind crossover study. ( Hua, AS; Kalowski, S; Kincaid-Smith, P; Whitworth, JA, 1980) |
| "1 Labetalol, an alpha- and beta- adrenoceptor blocking drug, was compared with acebutolol, alone or associated with dihydralazine in forty patients with moderate essential hypertension." | 9.05 | Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. ( Corvol, P; Lardoux, MD; Thibonnier, M, 1980) |
| "In an open study of fifteen patients with essential hypertension, acebutolol, a cardioselective B 1-adrenoceptor antagonist given orally once daily at dosages of between 400 mg and 1200 mg, produced a substantial and progressive reduction in systolic and diastolic arterial pressure and in the tension time index both in the lying and standing position over the 3 months of the trial." | 9.05 | An open study of acebutolol, given as a single daily dose in the management of hypertension in the Chulalungkorn Hospital, Thailand. ( Baker, PG; Goulton, J; Ongcharit, C, 1980) |
| "The efficacy and acceptability of single daily doses of a fixed combination of 400 mg acebutolol and 25 mg hydrochlorothiazide were assessed in an open study of 30 patients suffering from mild to moderate essential hypertension." | 9.05 | Assessment of the efficacy and acceptability of an acebutolol/hydrochlorothiazide combination in the treatment of mild to moderate essential hypertension. ( Harvard, CW; Nievel, JG, 1981) |
| "In a double-blind crossover study, the antihypertensive effect of hydrochlorothiazide alone and in combination with the beta blocker acebutolol was assessed in 18 patients suffering from mild to moderate hypertension." | 9.05 | Merits of adding a beta blocker (acebutolol) to a diuretic (hydrochlorothiazide) in the treatment of hypertension. ( Belleau, LJ; Brossard, JJ; Lebel, M, 1982) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 9.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "In a multicenter, double-blind comparison of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension (diastolic blood pressure, 95 to 114 mm Hg) in 182 and 178 patients, respectively, each agent reduced systolic and diastolic pressures to a similar significant degree: acebutolol, 15." | 9.05 | Comparison of acebutolol and hydrochlorothiazide in essential hypertension. ( Lewis, JE, 1985) |
| "A comparison of once-daily and twice-daily regimens of treatments with a beta-adrenoceptor-blocking agent, acebutolol, was carried out in patients with mild to moderate essential hypertension." | 9.05 | Once-daily administration of acebutolol in treatment of hypertension. ( Drayer, JI; Weber, MA, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 9.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "116 patients from 4 clinics participated in a double blind study to assess the efficacy of (BAY l 5240), a nifedipine-acebutolol fixed combination (10 mg + 100 mg), as compared to nifedipine 20 mg in essential hypertension." | 9.05 | Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine. ( Gfrerer, G; Gunselmann, W; Hennies, L; Hess, K; Lejeune, P; Rittgerodt, K; Schreiber, U; Winn, K, 1985) |
| "To evaluate the efficacy of acebutolol, 400-600 mg/day in elderly hypertensive patients, and to compare it with hydrochlorothiazide 25-50 mg/day, 45 patients with mild-moderate uncomplicated hypertension were treated for 6 weeks in a multicentre, single-blind, randomized, crossover trial." | 9.05 | Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly. ( Airoldi, G; Cagianelli, MA; Cinotti, G; Cortese, R; Diamanti, G; Giuntoli, F; Lucchini, M; Pedrinelli, R; Pettinà, G; Salvetti, A, 1985) |
| "Twenty patients with mild to moderate essential hypertension completed this double-blind cross-over randomized clinical trial of propranolol and acebutolol." | 9.05 | Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sethi, V; Sharma, BK; Sharma, PL; Wahl, PL, 1985) |
| "114 patients from four clinics participated in a double blind study designed to assess the efficacy of a nifedipine-acebutolol fixed combination -10 mg + 100 mg - as compared with acebutolol -200 mg- in essential hypertension." | 9.05 | Effects of a fixed combination of low dose nifedipine and acebutolol on essential hypertension: comparison with standard dose acebutolol. ( Gfrerer, G; Gunselmann, W; Hoppe, I; Lejeune, P; Mummel, P; Petersen, B; Schreiber, U; Winkler, E, 1985) |
| "Acebutolol was compared to atenolol in 33 patients with mild to moderate essential hypertension (diastolic blood pressure greater than 95 mm Hg) with the use of a double-blind crossover study design." | 9.05 | Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison. ( Brocklehurst, JC; Napier, RN; Turner, AS, 1985) |
| "Ambulatory monitoring of BP was performed in 11 patients whose 6 suffering from systo-diastolic (group 1) and 5 from systolic hypertension only (group 2) by Pressurometer III Del Mar Avionics after placebo (P), slow release Nifedipine (srN) 20 mg b." | 9.05 | Ambulatory BP monitoring after acute administration of slow release nifedipine, alone or in combination with acebutolol, in systo-diastolic and in systolic hypertension. ( Giannola, A; Immordino, R; Indovina, G; Novo, S; Raineri, A; Strano, A, 1985) |
| "Acebutolol, a new cardioselective beta-blocking agent, was administered for 48 hours to 44 patients with essential hypertension at a total dosage of 2." | 9.04 | Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker). ( Bertagna, X; Corvol, P; Degoulet, P; Menard, J; N'Guyen, PT, 1976) |
| "Acebutolol, a new cardioselective beta-adrenoceptor blocking agent, has been evaluated for the treatment of hypertension." | 9.04 | Controlled trial of acebutolol in hypertension. ( Andersson, O; Berglund, G; Hansson, L; Holm, M, 1977) |
| "The efficacy of single daily doses of acebutolol, alone or combined with chlorexolone, was investigated in a group of 20 ambulant patients with uncomplicated hypertension of mild-to-moderate severity." | 9.04 | Treatment of hypertension with single daily doses of acebutolol. ( Asmal, AC; Leary, WP; Marwick, B; Williams, PC, 1978) |
| "In a randomized crossover comparison between acebutolol and methyldopa for the treatment of mild to moderate essential hypertension in 30 patients, acebutolol, a cardioselective beta-one-adrenergic blocker, at 400 to 800 mg daily was found to be significantly better (p less than 0." | 9.04 | A randomized crossover comparison of acebutolol and methyldopa in the treatment of mild to moderate essential hypertension. ( Chatterji, AN, 1978) |
| "An open multicentre study was carried out under uncontrolled conditions in general practice to investigate the efficacy and acceptability of twice daily acebutolol in patients with mild to severe hypertension." | 9.04 | A multicentre study of twice daily acebutolol ('Sectral') in the treatment of hypertension in general practice. ( Baker, PG; Goulton, J, 1979) |
| "The tolerance and antihypertensive action of acebutolol, as a sole drug and in combination with a diuretic, were studied in a population of 34 female subjects aged over 65 years, with a mean of 81 years, suffering from well tolerated essential hypertension." | 9.04 | [The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)]. ( Berthaux, P; Forette, B; Forette, F; Henry, JF; Hervy, MP, 1979) |
| "The antihypertensive effect of acebutolol, a new cardioselective beta-blocking drug, is studied in 31 patients with mild essential hypertension." | 9.04 | [Acebutolol test in moderate arterial hypertension. Action on systolic time intervals]. ( Charpentier, A; Corvol, P; Degoulet, P; Ducrocq, MB; Ménard, J, 1975) |
| "Acebutolol, a new cardioselective blocking agent, has been used to treat essential hypertension during two years in 56 patients." | 9.04 | [Results of the treatment of essential arterial hypertension following prolonged (24 months administration of acebutolol)]. ( Fillastre, JP; Wolf, LM, 1975) |
| "Acebutolol was given to a group of 23 subjects with essential arterial hypertension associated with tachycardia at rest." | 9.04 | [Treatment of arterial hypertension with acebutolol. Clinical results]. ( Barjon, P; Fourcade, J; Mimran, A, 1975) |
| "This double-blind clinical study was carried out in order to compare the therapeutic activity of propranolol, and a new beta-adrenergic blocker, acebutolol, in essential hypertension." | 9.04 | [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension]. ( Tacquet, A, 1975) |
| "Acebutolol, a cardioselective beta-blocker, was studied at doses of 600 to 800 mg in a double-blind trial against placebo in 33 patients with essential hypertension." | 9.04 | [Treatment of arterial hypertension with acebutolol. Double-blind study with placebos]. ( Fillastre, JP; Letac, B; Safar, M; Wolf, LM, 1975) |
| "We compared the antihypertensive effects of acebutolol and metoprolol during 2-4 weeks of treatment in patients with mild to moderate essential hypertension." | 7.68 | [The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension]. ( Hayashi, T; Ichinohe, T; Ikeda, S; Ikeda, Y; Kawaguchi, K; Kotake, C; Koya, Y; Onaka, H; Seo, T; Suyama, K, 1992) |
| "In 78 patients with mild or moderate hypertension, effect of acebutolol and hydrochlorothiazide on plasma lipids, lipoproteins, fibrinogen and plasma fibrinolysis time were investigated." | 7.68 | [Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?]. ( Karolko, B; Kopel, E; Kübler, G; Witkowska, M, 1991) |
| "We report the case of myasthenia gravis in a 74-year-old woman, 2 weeks after acebutolol had been introduced as the sole treatment for systemic hypertension." | 7.68 | Fulminant myasthenia gravis soon after initiation of acebutolol therapy. ( Aimard, G; Charles, N; Confavreux, C, 1990) |
| "In 18 patients with mild or moderate essential hypertension who responded favorably to acebutolol antihypertensive therapy, echocardiography (echo) was performed in the basal condition and after 6 and 12 months of follow-up." | 7.67 | Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension. ( Condorelli, M; Cuocolo, A; De Luca, N; Ricciardelli, B; Trimarco, B; Veniero, A; Volpe, M, 1984) |
| "The efficacy and safety of long-term treatment with oral nitrendipine were evaluated in 34 patients with essential arterial hypertension." | 7.67 | Long-term treatment of essential arterial hypertension with nitrendipine. ( Amerio, S; Avogliero, G; Bo, L; Borgnino, C; Minelli, M; Rocci, R; Uslenghi, E, 1988) |
| "The authors follow up the effectiveness and tolerance of monotherapy with acebutolol in 47 patients with light and moderate hypertension, in a dose of 400-1200 mg in the course of three months." | 7.67 | [Treatment of light and moderate arterial hypertension with acebutolol]. ( Kaloianova, A; Nikolov, G; Sotirov, I; Tsanov, N; Tsolov, S, 1986) |
| "Twenty patients with essential hypertension were given 400 mg acebutolol once daily for 24 weeks." | 7.67 | Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese. ( Ogata, E; Ohnishi, T; Sekine, K; Takahashi, M; Takase, M, 1985) |
| "25 patients with essential arterial hypertension were treated with single daily doses of 400 g acebutolol administered for EIGHT weeks in outpatients' departments." | 7.66 | [Treatment of essential arterial hypertension with a single daily dose of acebutolol]. ( Cazzani, E; Muzio, L; Romanò, M; Saettone, GP, 1983) |
| "Twenty pregnant women with mild to moderate hypertension were treated with either methyldopa or acebutolol, a beta-adrenergic blocking agent with cardioselectivity and intrinsic sympathomimetic activity, in a prospective open study." | 7.66 | A comparison of acebutolol with methyldopa in hypertensive pregnancy. ( Morrissey, JR; Williams, ER, 1983) |
| "The antihypertensive effect of 2,000 mg of acebutolol investigated with an acute 48 hr test in 60 diabetic and 60 non-diabetic in-patients with essential hypertension." | 7.66 | Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol. ( Canivet, J; Gauville, C; Passa, P; Tugaye, A, 1981) |
| "In eleven subjects with normal blood-pressure, but with reactive blood-hypertension revealed by bicycle ergometer testing, oral acebutolol in single daily dose of 400 mg was administered." | 7.66 | [Acebutolol in the treatment of stress-reactive hypertension. A medium term open study]. ( Bondi, S; Ciglia, C; Leonzio, L; Mattoscio, N; Rossi, A, 1982) |
| "The antihypertensive effect of acebutolol 400 mg and hydrochlorothiazide 25 mg in combination have been assessed in 22 patients with mild, moderate and severe hypertension." | 7.66 | The use of acebutolol with hydrochlorothiazide in hypertension. ( Darmadji, T; Pikir, BS; Saleh, M; Yogiarto, M, 1981) |
| "Acebutolol (ABL) and hydrochlorothiazide (HCT) were compared in patients with mild to moderate essential hypertension and low or normal peripheral renin activity." | 7.66 | Acebutolol and hydrochlorothiazide in essential hypertension. ( Brossard, JJ; Nadeau, J; Ogilvie, RI; Ruedy, J, 1980) |
| "Eleven patients with essential hypertension were treated with the beta adrenergic blocker, acebutolol." | 7.66 | Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume. ( Aristimuno, GG; Dreslinski, GR; Frohlich, ED; Messerli, FH; Suarez, DH, 1979) |
| "Acebutolol, a new cardioselective beta-blocking agent, has been given for 5 days, at a daily dosage of 600 mg to 8 patients with mild essential hypertension." | 7.65 | [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension]. ( Corvol, P; Ménard, J; Plouin, PF, 1975) |
| "Hypertension is one of the most important risk factors for ischaemic heart disease and stroke." | 6.70 | [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment]. ( Franczuk, P; Janicki, K; Pieniazek, W, 2001) |
| "Acebutolol was superior to placebo, propranolol, and hydrochlorothiazide in terms of response rate." | 6.66 | Effects of age and race on clinical response to acebutolol in essential hypertension. ( Boyles, PW, 1985) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 6.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| "02; 2--A more frequent adjustment of daily dosage with MD (n = 15) than with ACE (n = 10) or LAB (n = 7); 3--The absence of any significant difference for uricemia level, platelet counts, foetal cardiac rythm, and occurrence of pre-eclampsia (MD = 4; ACE = 3; LAB = 4; 4--An equivalent birth-weight (MD = 3110 +/- 628 g; ACE = 3115 +/- 645." | 6.66 | [Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol]. ( Blazquez, G; Gérard, J; Lardoux, H; Leperlier, E, 1988) |
| "Acebutolol treatment induced reduction in diastolic pressure, heart rate, and PRA pooled from both phases of the study." | 6.65 | Addition of acebutolol to diuretics in hypertension. ( Dziedzic, SW; Elijovich, F; Gorkin, JU; Krakoff, LR, 1981) |
| "Both acebutolol treatments reduced the response; the reduction after twice daily treatment (mean 25 beats/min) was significantly greater than after once daily treatment (mean 19 beats/min)." | 6.65 | Comparison of once and twice daily administration of acebutolol in hypertension. ( Littler, WA; Stallard, TJ; Watson, RD, 1980) |
| "Acebutolol appears to be a useful anti-hypertensive in the management of hypertension." | 6.64 | Clinical trial of acebutolol (Sectral) in hypertension. ( Charoenlarp, K; Jaroonvesama, N, 1978) |
| " Optimum dosage defined in an open assessment varied from 200--600 mg twice daily." | 6.64 | Acebutolol in hypertension--double-blind trial against placebo. ( Martin, MA; Phillips, CA; Smith, AJ, 1978) |
| " Dosage can be progressively increased up to 30 mg/day." | 6.64 | [Prazosine: a new vasodilator used for treatment of hypertension (author's transl)]. ( Bret, M; Fillastre, JP; Godin, M, 1978) |
| " The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated." | 6.64 | [Acebutolol in the treatment of arterial hypertension. Clinical study]. ( Chaignon, M; Guédon, J; Lucsko, M, 1975) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 6.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Sixty patients with arterial hypertension randomized in three groups were studied before and after treatment with atenolol (AT), acebutolol (AC) or talinolol (TL) until doses of 100, 600 and 300 mg/d correspondingly were reached or resting HR was decreased by 10 bpm." | 5.12 | [Interrelationship between changes of rate and variability of cardiac rhythm under influence of beta-adrenoblockers]. ( Alekseeva, IuM; Malkina, TA; Sokolov, SF, 2007) |
| "40 patients with essential hypertension were studied to ascertain the effects of a selective b1-blocker (acebutolol, 400 mg/day) on serum lipids, antioxidant status, antioxidant enzyme activity in red blood cells (RBC), and membrane fatty acids composition." | 5.10 | Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. ( Belleville, JL; Bouchenak, M; Cherrad, A; Krouf, D; Mohammedi, B; Prost, JL, 2003) |
| "The main purpose of our study was to analyse efficacy and safety of acebutolol (Sectral) in the treatment of hypertension in pregnancy." | 5.10 | [Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents]. ( Kriska, M; Letkovicová, M; Mlyncek, M; Sirotiaková, J, 2002) |
| "Among patients with mild-to-moderate hypertension both acebutolol and perindopril beneficially decreased cerebrovascular resistance and increased the CBF index in comparison with placebo." | 5.09 | Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients. ( Dimitrow, PP; Jasiński, T; Pieniazek, W, 2001) |
| "A relationship between individual variations of the oxidative and acetylating metabolism rates of penbutolol, propranolol, acebutolol which produce a hypotensive effect was studied in patients with arterial hypertension." | 5.07 | [Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension]. ( Bredikhin, VT; Dementéva, NG; Filippenko, NG; Povetkin, SV; Smirnova, II, 1993) |
| "The antihypertensive efficacy of single-drug therapy with nifedipine (N), prazosin (P), or acebutolol (A) and the influence of these agents on coronary risk factors including hypoglycemia, hyperuricemia, and hyperlipidemia, were studied in adolescents with hypertension." | 5.07 | [Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents]. ( Cichocka, E; Januszewicz, P; Wyszynska, T, 1993) |
| " Acebutolol or enalapril were given double-blind to 17 patients with uncomplicated moderate essential hypertension." | 5.07 | [Ambulatory or single measurement of blood pressure: comparison in a controlled trial in patients with hypertension]. ( Barthelmebs, M; Imbs, JL; Stephan, D; Welsch, M, 1993) |
| "The addition of enalapril or acebutolol to a regimen of altizide + spironolactone in patients with moderate hypotension was investigated in a multicenter study of 53 patients." | 5.06 | Spironolactone and altizide used in combination with enalapril: twenty-four-hour ambulatory recording of blood pressure. ( Capron, MH; Pelletier, B; Poncelet, P; Wehrlen, M, 1990) |
| "The efficacy of the calcium channel blocker nitrendipine alone and in combination with the beta blocking agent acebutolol or hydrochlorothiazide was tested in 34 patients with moderate essential hypertension." | 5.06 | [Therapy of moderate hypertension with the calcium antagonist nitrendipine in combination with beta receptor blocker or diuretic]. ( Kolloch, R; Müller, HM; Overlack, A; Stumpe, KO, 1990) |
| "The efficacy, tolerance and effect on serum lipids of acebutolol were compared with those of atenolol over a 6-month period in a large group of patients with mild arterial hypertension." | 5.06 | Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension. ( De Backer, G, 1988) |
| "In a randomised, crossover study of patients with moderate to severe essential hypertension, the effects of the calcium entry antagonist nifedipine and the beta-receptor blocking drug acebutolol were studied on their own, and in combination." | 5.06 | Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension. ( MacGregor, GA; Markandu, ND; Shore, AC; Singer, DR, 1987) |
| "Acebutolol, a beta-1 selective beta blocker with intrinsic sympathomimetic activity has been shown to be an effective agent in chronic angina pectoris therapy, with twice or three times daily dosing." | 5.06 | Low-dose acebutolol given once daily in the treatment of chronic angina pectoris. ( Piña, IL; Smith, EV; Weidler, DJ, 1988) |
| "A double-blind multicenter study compared oral acebutolol (n = 182) with hydrochlorothiazide (n = 178) in the treatment of mild to moderate essential hypertension (diastolic blood pressure 95 to 114 mm Hg)." | 5.06 | Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation. ( Singh, BN; Thoden, WR; Wahl, J, 1986) |
| "The effects of acebutolol (with intrinsic sympathomimetic activity (ISA] and metoprolol (without ISA) on arm blood pressure, ankle systolic blood pressure, claudication distances (CD) and maximal walking distances (MWD) were compared in patients with essential hypertension and intermittent claudication." | 5.06 | The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication. ( Jelnes, R; Svendsen, TL; Tønnesen, KH, 1986) |
| "A double-blind, parallel group comparison study was carried out in 20 diabetic patients with mild to moderate hypertension to assess the effectiveness and tolerance of acebutolol compared with placebo." | 5.06 | Acebutolol in the treatment of diabetic patients with hypertension. ( Fraser, DM; Nimmo, GR; Poloniecki, JD, 1986) |
| "The haemodynamic effects of piretanide, acebutolol and nifedipine were tested and compared at rest and on exercise in an open study of patients with essential hypertension, grade II (WHO)." | 5.06 | [Modification of resting and effort hemodynamics in essential arterial hypertension using antihypertensive agents]. ( Wiechmann, HW, 1987) |
| "32 patients (13 women and 19 men) with slight to severe hypertension were treated during an open medium term study with acebutolol, a beta-antagonist which is cardioselective and at the same time has an intrinsic sympatheticomimetic effect." | 5.05 | [Acebutolol: experience with its use in ambulatory management of arterial hypertension]. ( Adamo, M; Battaglia, A, 1983) |
| "5 mg of slow-release (sr) clonidine, 800 mg of acebutolol, and of both drugs combined on blood pressure and the water-salt balance were compared in 10 patients with essential hypertension." | 5.05 | Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance. ( Cornette, M; Degoulet, P; Fermé, I; Ménard, J; Plouin, PF, 1983) |
| "One thousand four hundred and two patients with essential hypertension were treated by their general practitioners for 3 months with one tablet daily consisting of 200 mg acebutolol plus 12." | 5.05 | Treatment of essential hypertension with beta-blocker plus diuretic: a study of 1402 patients treated by general practitioners with acebutolol 200 mg combined with hydrochlorothiazide 12.5 mg ('Secadrex') once daily for 3 months. ( Baker, PG; McGowan, GK, 1984) |
| "The antihypertensive efficacy and the acceptability of nifedipine (NI, Adalat) and the usefulness of its combination with a beta 1-selective blocking drug, acebutolol (AC), were studied in a placebo controlled trial on 15 patients with moderate hypertension." | 5.05 | Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability. ( de Divitiis, O; Di Somma, S; Fazio, S; Galderisi, M; Liguori, V; Petitto, M; Santomauro, M; Villari, B, 1984) |
| "The efficacy and acceptability of a single half-tablet daily of a fixed combination of 400 mg acebutolol and 25 mg hydrochlorothiazide was assessed in a study of 35 patients suffering from mild to moderate essential hypertension." | 5.05 | The efficacy and acceptability of the combination of acebutolol and hydrochlorothiazide in the treatment of essential hypertension. ( Sugeng, I; Suryaatmaja, M; Sutandar, H; Utama, H, 1984) |
| "A double-blind, crossover comparison of once-daily acebutolol (400 mg) and once-daily atenolol (100 mg) was carried out in 33 patients with mild to moderate essential hypertension." | 5.05 | Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension. ( Brocklehurst, JC; Turner, AS, 1983) |
| "The effect of acebutolol (Sectral) was compared with that of placebo in 30 patients with mild to moderate hypertension who were receiving a thiazide diuretic." | 5.05 | Acebutolol in mild to moderate hypertension: a double-blind crossover study. ( Hua, AS; Kalowski, S; Kincaid-Smith, P; Whitworth, JA, 1980) |
| "1 Labetalol, an alpha- and beta- adrenoceptor blocking drug, was compared with acebutolol, alone or associated with dihydralazine in forty patients with moderate essential hypertension." | 5.05 | Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. ( Corvol, P; Lardoux, MD; Thibonnier, M, 1980) |
| "In an open study of fifteen patients with essential hypertension, acebutolol, a cardioselective B 1-adrenoceptor antagonist given orally once daily at dosages of between 400 mg and 1200 mg, produced a substantial and progressive reduction in systolic and diastolic arterial pressure and in the tension time index both in the lying and standing position over the 3 months of the trial." | 5.05 | An open study of acebutolol, given as a single daily dose in the management of hypertension in the Chulalungkorn Hospital, Thailand. ( Baker, PG; Goulton, J; Ongcharit, C, 1980) |
| "The efficacy and acceptability of single daily doses of a fixed combination of 400 mg acebutolol and 25 mg hydrochlorothiazide were assessed in an open study of 30 patients suffering from mild to moderate essential hypertension." | 5.05 | Assessment of the efficacy and acceptability of an acebutolol/hydrochlorothiazide combination in the treatment of mild to moderate essential hypertension. ( Harvard, CW; Nievel, JG, 1981) |
| "In a double-blind crossover study, the antihypertensive effect of hydrochlorothiazide alone and in combination with the beta blocker acebutolol was assessed in 18 patients suffering from mild to moderate hypertension." | 5.05 | Merits of adding a beta blocker (acebutolol) to a diuretic (hydrochlorothiazide) in the treatment of hypertension. ( Belleau, LJ; Brossard, JJ; Lebel, M, 1982) |
| "1 In a placebo-controlled study, the respective anti-hypertensive effects of hydrochlorothiazide and hydrochlorothiazide plus the beta-adrenoceptor blocker acebutolol were assessed in 18 patients with moderately severe essential hypertension." | 5.05 | Antihypertensive action of acebutolol (Sectral) when used concomitantly with hydrochlorothiazide. ( Brossard, JJ; McKenzie, JK; Mitenko, PA, 1982) |
| " Therefore the ability of the beta-receptor antagonist acebutolol (400 mg/die) and of the diuretic mefrusid (25 mg/die) to reduce exercise-induced increases in blood pressure and pressure-rate product during and after standardized ergometric work (50--100 watts) was compared in a within-patient study of 42 outpatients with arterial hypertension (stage 1 to 2, WHO) aged 18 to 50 years." | 5.05 | [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)]. ( Franz, IW, 1982) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 5.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "In a multicenter, double-blind comparison of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension (diastolic blood pressure, 95 to 114 mm Hg) in 182 and 178 patients, respectively, each agent reduced systolic and diastolic pressures to a similar significant degree: acebutolol, 15." | 5.05 | Comparison of acebutolol and hydrochlorothiazide in essential hypertension. ( Lewis, JE, 1985) |
| "A comparison of once-daily and twice-daily regimens of treatments with a beta-adrenoceptor-blocking agent, acebutolol, was carried out in patients with mild to moderate essential hypertension." | 5.05 | Once-daily administration of acebutolol in treatment of hypertension. ( Drayer, JI; Weber, MA, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 5.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "116 patients from 4 clinics participated in a double blind study to assess the efficacy of (BAY l 5240), a nifedipine-acebutolol fixed combination (10 mg + 100 mg), as compared to nifedipine 20 mg in essential hypertension." | 5.05 | Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine. ( Gfrerer, G; Gunselmann, W; Hennies, L; Hess, K; Lejeune, P; Rittgerodt, K; Schreiber, U; Winn, K, 1985) |
| "To evaluate the efficacy of acebutolol, 400-600 mg/day in elderly hypertensive patients, and to compare it with hydrochlorothiazide 25-50 mg/day, 45 patients with mild-moderate uncomplicated hypertension were treated for 6 weeks in a multicentre, single-blind, randomized, crossover trial." | 5.05 | Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly. ( Airoldi, G; Cagianelli, MA; Cinotti, G; Cortese, R; Diamanti, G; Giuntoli, F; Lucchini, M; Pedrinelli, R; Pettinà, G; Salvetti, A, 1985) |
| "Twenty patients with mild to moderate essential hypertension completed this double-blind cross-over randomized clinical trial of propranolol and acebutolol." | 5.05 | Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sethi, V; Sharma, BK; Sharma, PL; Wahl, PL, 1985) |
| "114 patients from four clinics participated in a double blind study designed to assess the efficacy of a nifedipine-acebutolol fixed combination -10 mg + 100 mg - as compared with acebutolol -200 mg- in essential hypertension." | 5.05 | Effects of a fixed combination of low dose nifedipine and acebutolol on essential hypertension: comparison with standard dose acebutolol. ( Gfrerer, G; Gunselmann, W; Hoppe, I; Lejeune, P; Mummel, P; Petersen, B; Schreiber, U; Winkler, E, 1985) |
| "The aim of this study was to test the efficacy of a 20 mg tablet preparation of nifedipine alone in twice daily dosage, in the treatment of moderate hypertension (95 greater than or equal to DBP less than or equal to 115 mmHg)." | 5.05 | [Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration]. ( Bénichou, M; Griener, L; Kerihuel, JC; Perchicot, E; Serradimigni, A, 1985) |
| "Acebutolol was compared to atenolol in 33 patients with mild to moderate essential hypertension (diastolic blood pressure greater than 95 mm Hg) with the use of a double-blind crossover study design." | 5.05 | Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison. ( Brocklehurst, JC; Napier, RN; Turner, AS, 1985) |
| "Ambulatory monitoring of BP was performed in 11 patients whose 6 suffering from systo-diastolic (group 1) and 5 from systolic hypertension only (group 2) by Pressurometer III Del Mar Avionics after placebo (P), slow release Nifedipine (srN) 20 mg b." | 5.05 | Ambulatory BP monitoring after acute administration of slow release nifedipine, alone or in combination with acebutolol, in systo-diastolic and in systolic hypertension. ( Giannola, A; Immordino, R; Indovina, G; Novo, S; Raineri, A; Strano, A, 1985) |
| "Acebutolol, a new cardioselective beta-blocking agent, was administered for 48 hours to 44 patients with essential hypertension at a total dosage of 2." | 5.04 | Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker). ( Bertagna, X; Corvol, P; Degoulet, P; Menard, J; N'Guyen, PT, 1976) |
| "Atenolol was compared with five other beta-blockers and a thiazide diuretic in a randomised cross-over trial of once-daily treatment of essential hypertension." | 5.04 | Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. ( Wilcox, RG, 1978) |
| "Acebutolol, a new cardioselective beta-adrenoceptor blocking agent, has been evaluated for the treatment of hypertension." | 5.04 | Controlled trial of acebutolol in hypertension. ( Andersson, O; Berglund, G; Hansson, L; Holm, M, 1977) |
| "The efficacy of single daily doses of acebutolol, alone or combined with chlorexolone, was investigated in a group of 20 ambulant patients with uncomplicated hypertension of mild-to-moderate severity." | 5.04 | Treatment of hypertension with single daily doses of acebutolol. ( Asmal, AC; Leary, WP; Marwick, B; Williams, PC, 1978) |
| "In a randomized crossover comparison between acebutolol and methyldopa for the treatment of mild to moderate essential hypertension in 30 patients, acebutolol, a cardioselective beta-one-adrenergic blocker, at 400 to 800 mg daily was found to be significantly better (p less than 0." | 5.04 | A randomized crossover comparison of acebutolol and methyldopa in the treatment of mild to moderate essential hypertension. ( Chatterji, AN, 1978) |
| "An open multicentre study was carried out under uncontrolled conditions in general practice to investigate the efficacy and acceptability of twice daily acebutolol in patients with mild to severe hypertension." | 5.04 | A multicentre study of twice daily acebutolol ('Sectral') in the treatment of hypertension in general practice. ( Baker, PG; Goulton, J, 1979) |
| "The tolerance and antihypertensive action of acebutolol, as a sole drug and in combination with a diuretic, were studied in a population of 34 female subjects aged over 65 years, with a mean of 81 years, suffering from well tolerated essential hypertension." | 5.04 | [The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)]. ( Berthaux, P; Forette, B; Forette, F; Henry, JF; Hervy, MP, 1979) |
| "The antihypertensive effect of acebutolol, a new cardioselective beta-blocking drug, is studied in 31 patients with mild essential hypertension." | 5.04 | [Acebutolol test in moderate arterial hypertension. Action on systolic time intervals]. ( Charpentier, A; Corvol, P; Degoulet, P; Ducrocq, MB; Ménard, J, 1975) |
| "Acebutolol, a new cardioselective blocking agent, has been used to treat essential hypertension during two years in 56 patients." | 5.04 | [Results of the treatment of essential arterial hypertension following prolonged (24 months administration of acebutolol)]. ( Fillastre, JP; Wolf, LM, 1975) |
| "Acebutolol was given to a group of 23 subjects with essential arterial hypertension associated with tachycardia at rest." | 5.04 | [Treatment of arterial hypertension with acebutolol. Clinical results]. ( Barjon, P; Fourcade, J; Mimran, A, 1975) |
| "This double-blind clinical study was carried out in order to compare the therapeutic activity of propranolol, and a new beta-adrenergic blocker, acebutolol, in essential hypertension." | 5.04 | [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension]. ( Tacquet, A, 1975) |
| "Acebutolol, a cardioselective beta-blocker, was studied at doses of 600 to 800 mg in a double-blind trial against placebo in 33 patients with essential hypertension." | 5.04 | [Treatment of arterial hypertension with acebutolol. Double-blind study with placebos]. ( Fillastre, JP; Letac, B; Safar, M; Wolf, LM, 1975) |
| "During 10 years of clinical use involving almost 3 million patient-years, acebutolol has become established as a remarkably safe and well-tolerated beta-blocking agent, effective in treating essential hypertension and cardiac arrhythmias." | 4.77 | Acebutolol: ten years of experience. ( De Bono, G; Kaye, CM; Roland, E; Summers, AJ, 1985) |
| "The ongoing Treatment of Mild Hypertension Study, now in its third year, has evaluated 847 patients to date with regard to lipid profile." | 3.76 | Acebutolol effects on lipid profile. ( Schnaper, HW, 1990) |
| "This study was conducted to investigate the effects of long-term administration of a calcium-channel antagonist (nifedipine) and a beta-blocker (acebutolol) on physical fitness in men with mild hypertension." | 3.69 | Effects of long-term antihypertensive therapy on physical fitness of men with mild hypertension. ( Doba, N; Hinohara, S; Kajiwara, N; Kanmatsuse, K; Kushiro, T; Tomiyama, H; Yamashita, M; Yoshida, H, 1997) |
| "We compared the antihypertensive effects of acebutolol and metoprolol during 2-4 weeks of treatment in patients with mild to moderate essential hypertension." | 3.68 | [The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension]. ( Hayashi, T; Ichinohe, T; Ikeda, S; Ikeda, Y; Kawaguchi, K; Kotake, C; Koya, Y; Onaka, H; Seo, T; Suyama, K, 1992) |
| "A prospective study of the hemodynamic and renal changes was undertaken in 11 neonates whose mothers were treated with acebutolol for hypertension during pregnancy, compared with a control group of 11 infants born to normotensive mothers." | 3.68 | [Hemodynamic and renal adaptation of newborn infants of hypertensive mothers treated with acebutolol]. ( Boutroy, MJ; Monin, P; Vert, P; Yassen, H, 1992) |
| "In 78 patients with mild or moderate hypertension, effect of acebutolol and hydrochlorothiazide on plasma lipids, lipoproteins, fibrinogen and plasma fibrinolysis time were investigated." | 3.68 | [Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?]. ( Karolko, B; Kopel, E; Kübler, G; Witkowska, M, 1991) |
| "We report the case of myasthenia gravis in a 74-year-old woman, 2 weeks after acebutolol had been introduced as the sole treatment for systemic hypertension." | 3.68 | Fulminant myasthenia gravis soon after initiation of acebutolol therapy. ( Aimard, G; Charles, N; Confavreux, C, 1990) |
| "In 18 patients with mild or moderate essential hypertension who responded favorably to acebutolol antihypertensive therapy, echocardiography (echo) was performed in the basal condition and after 6 and 12 months of follow-up." | 3.67 | Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension. ( Condorelli, M; Cuocolo, A; De Luca, N; Ricciardelli, B; Trimarco, B; Veniero, A; Volpe, M, 1984) |
| "The effect on plasma lipids of acebutolol given orally over a 6-month period to 18 patients with essential hypertension was studied." | 3.67 | The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels. ( Lehtonen, A, 1984) |
| "Fourteen patients with previously untreated essential hypertension and left ventricular hypertrophy were treated with a fixed-dose combination of acebutolol 200 mg and nifedipine 20 mg once daily for a followup of 25." | 3.67 | Regression of left ventricular hypertrophy by acebutolol and nifedipine. ( Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U, 1989) |
| "A patient with essential hypertension receiving the oral administration of acebutolol, a beta 1-selective adrenergic blocker, showed a marked increase in urinary 17-ketosteroid (17-KS) excretion determined by Zimmermann's method." | 3.67 | The interference of acebutolol administration in the measurement of urinary 17-ketosteroid by Zimmermann's method. ( Iimura, O; Nakagawa, M; Ooiwa, H; Shimamoto, K, 1988) |
| "The efficacy and safety of long-term treatment with oral nitrendipine were evaluated in 34 patients with essential arterial hypertension." | 3.67 | Long-term treatment of essential arterial hypertension with nitrendipine. ( Amerio, S; Avogliero, G; Bo, L; Borgnino, C; Minelli, M; Rocci, R; Uslenghi, E, 1988) |
| "The authors follow up the effectiveness and tolerance of monotherapy with acebutolol in 47 patients with light and moderate hypertension, in a dose of 400-1200 mg in the course of three months." | 3.67 | [Treatment of light and moderate arterial hypertension with acebutolol]. ( Kaloianova, A; Nikolov, G; Sotirov, I; Tsanov, N; Tsolov, S, 1986) |
| "Twenty patients with essential hypertension were given 400 mg acebutolol once daily for 24 weeks." | 3.67 | Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese. ( Ogata, E; Ohnishi, T; Sekine, K; Takahashi, M; Takase, M, 1985) |
| "The effect on plasma apoproteins A-I and B and HDL cholesterol subfractions of acebutolol given orally over a 6-month period to 18 patients with essential hypertension was studied." | 3.67 | The effect of acebutolol on plasma apoproteins and HDL cholesterol subfractions. ( Lehtonen, A; Marniemi, J; Niittymäki, K, 1985) |
| "Intra-arterial blood pressure recordings were studied in 10 ambulant subjects with essential hypertension to evaluate the effect of a single daily dose of acebutolol." | 3.67 | The lowering of daytime blood pressures with a single daily dose of acebutolol in ambulant hypertensives. ( Goldberg, AD; Mehta, SK; Walsh, JT, 1985) |
| "The blood presure abilities of the beta receptor antagonist acebutolol and the fixed diuretic combination of hydrochlorothiazide/amiloride hydrochloride to reduce exercise-induced increases in blood presure durng and after standardized ergometric work were compared in a within-patient study of patients with uncomplicated essential hypertension." | 3.66 | Differential antihypertensive effect of acebutolol and hydrochlorothiazide/amiloride hydrochloride combination on elevated exercise blood pressures in hypertensive patients. ( Franz, IW, 1980) |
| " Propranolol, acebutolol and practolol, at a daily dose of 50 mg/kg, prevented the occurrence of hypertension, not only during the 4 weeks of treatment, but also during 6,9 and 11 weeks respectively after cessation of treatment." | 3.66 | Variability in the preventive action of the B-blockers on genetic hypertension in the rat. ( Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP, 1980) |
| "25 patients with essential arterial hypertension were treated with single daily doses of 400 g acebutolol administered for EIGHT weeks in outpatients' departments." | 3.66 | [Treatment of essential arterial hypertension with a single daily dose of acebutolol]. ( Cazzani, E; Muzio, L; Romanò, M; Saettone, GP, 1983) |
| "Twenty pregnant women with mild to moderate hypertension were treated with either methyldopa or acebutolol, a beta-adrenergic blocking agent with cardioselectivity and intrinsic sympathomimetic activity, in a prospective open study." | 3.66 | A comparison of acebutolol with methyldopa in hypertensive pregnancy. ( Morrissey, JR; Williams, ER, 1983) |
| "Systolic blood pressure, heart rate, and blood glucose concentration were measured in the first three days of life in 10 infants born to mothers who had received acebutolol, a cardioselective beta-adrenergic-blocking agent, for hypertension in pregnancy and compared with values in 10 infants whose mothers had received methyldopa." | 3.66 | Neonatal effects of maternal administration of acebutolol. ( Amiel-Tison, C; Dumez, Y; Hornych, H; Tchobroutsky, C, 1981) |
| "The effects of propranolol (100 mg/kg), atenolol (200 mg/kg) and acebutolol (1000 mg/kg) administered daily by gavage to spontaneously hypertensive rats (SHRs) from their 6th to 20th weeks of age were investigated on genetic hypertension development (GHD) and at regular intervals on heart rate (HR), cardiac output (CO), stroke volume (SV), peripheral resistence (PR), plasma renin concentration (PRC) and heart weight/body weight ratio (HW/BW)." | 3.66 | beta-Adrenoreceptor blockage and genetic hypertension development in rats. ( Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N, 1980) |
| "The antihypertensive effect of 2,000 mg of acebutolol investigated with an acute 48 hr test in 60 diabetic and 60 non-diabetic in-patients with essential hypertension." | 3.66 | Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol. ( Canivet, J; Gauville, C; Passa, P; Tugaye, A, 1981) |
| "In eleven subjects with normal blood-pressure, but with reactive blood-hypertension revealed by bicycle ergometer testing, oral acebutolol in single daily dose of 400 mg was administered." | 3.66 | [Acebutolol in the treatment of stress-reactive hypertension. A medium term open study]. ( Bondi, S; Ciglia, C; Leonzio, L; Mattoscio, N; Rossi, A, 1982) |
| "The results of a multi-centre general practice study on acebutolol in the treatment of hypertension were examined for two age groups of patients, namely those aged from 50 to 64 years and those aged 65 years and over." | 3.66 | Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64-years' old and over 65 years' old age groups. ( Baker, PG; Goulton, J; Guerin, A, 1981) |
| "The antihypertensive effect of acebutolol 400 mg and hydrochlorothiazide 25 mg in combination have been assessed in 22 patients with mild, moderate and severe hypertension." | 3.66 | The use of acebutolol with hydrochlorothiazide in hypertension. ( Darmadji, T; Pikir, BS; Saleh, M; Yogiarto, M, 1981) |
| "Acebutolol (ABL) and hydrochlorothiazide (HCT) were compared in patients with mild to moderate essential hypertension and low or normal peripheral renin activity." | 3.66 | Acebutolol and hydrochlorothiazide in essential hypertension. ( Brossard, JJ; Nadeau, J; Ogilvie, RI; Ruedy, J, 1980) |
| "The effects of acebutolol (800 mg per day for three days) on pulse rate, blood pressure, plasma noradrenaline and plasma renin activity were measured in nine patients with essential hypertension, at rest in a horizontal position, after five minutes standing upright and after walking for one hour." | 3.66 | [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)]. ( Bohuon, C; Comoy, E; Corvol, P; Ménard, J; Plouin, PF, 1979) |
| "Eleven patients with essential hypertension were treated with the beta adrenergic blocker, acebutolol." | 3.66 | Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume. ( Aristimuno, GG; Dreslinski, GR; Frohlich, ED; Messerli, FH; Suarez, DH, 1979) |
| " Ocular surveillance, with examinations repeated every six months, indicated the absence of any harmful effect on the eye of prolonged used of acebutolol in the treatment of hypertension." | 3.66 | [Prolonged treatment with acebutolol: surveilance of ocular status (author's transl)]. ( Fillastre, JP; Letac, B; Wagner, C; Wolf, LM, 1978) |
| "Chronic hypertension has been produced in mongrel dogs by the long-term oral administration of metyrapone (100 mg/kg per day)." | 3.65 | Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs. ( Bravo, EL; Dustan, HP; Tarazi, RC, 1977) |
| " Acebutolol, a beta1-receptor blocker, has, at a daily dose of 800 mg, a mild but significant anti-hypertensive effect in moderate sustained essential hypertension with normal or low plasma renin activity." | 3.65 | Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities. ( Alexandre, JM; Bezoc, JF; Desmet, G; Fournier, A; Hardin, JM; Lombaert, M; Quichaud, J; Ronco, G, 1976) |
| "Acebutolol, a new cardioselective beta-blocking agent, has been given for 5 days, at a daily dosage of 600 mg to 8 patients with mild essential hypertension." | 3.65 | [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension]. ( Corvol, P; Ménard, J; Plouin, PF, 1975) |
| "Hypertension is one of the most important risk factors for ischaemic heart disease and stroke." | 2.70 | [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment]. ( Franczuk, P; Janicki, K; Pieniazek, W, 2001) |
| "100 hypertensive patients with chronic renal failure (initial serum creatinine 200-400 mumol/l." | 2.67 | Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. ( Chanard, J; Durand, D; el Esper, N; Fournier, A; Godin, M; Goldfarb, B; Hannedouche, T; Landais, P; Mignon, F; Suo, JM, 1994) |
| " Forty-six outpatients suffering from mild to moderate essential hypertension [diastolic blood pressure (DBP) ranging between 95 and 120 mm Hg] were randomly given either 10 mg of bisoprolol or 400 mg of acebutolol once a day for 8 weeks; this dosage was doubled after 4 weeks if DBP was still above 90 mm Hg." | 2.67 | Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study. ( Bouvier, JM; Herrero, G; Rabot, D, 1990) |
| " More specifically, a comparison of the two drugs during the final 6 hours (3 AM to 9 AM) of the dosing interval showed that the mean decrease in diastolic BP of 10." | 2.67 | Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements. ( Cheung, DG; Graettinger, WF; Neutel, JM; Schnaper, H; Weber, MA, 1990) |
| "Beta-blockers are commonly used in the treatment of hypertension." | 2.66 | Time course for blood pressure lowering of beta-blockers with partial agonist activity. ( Dormuth, C; Musini, VM; Soufi, S; Zhang, XY, 2020) |
| "Acebutolol was superior to placebo, propranolol, and hydrochlorothiazide in terms of response rate." | 2.66 | Effects of age and race on clinical response to acebutolol in essential hypertension. ( Boyles, PW, 1985) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 2.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| " The decrease in diastolic blood pressure at the end of the second week was significantly correlated with the reciprocal of the plasma celiprolol concentration at steady-state at the end of the dosage interval." | 2.66 | Comparison of the antihypertensive effects of celiprolol and acebutolol. ( Belovezhdov, N; Gerova, Z; Terziivanov, D; Vlahov, V, 1988) |
| " There was no evidence of a flat dose-response curve in the daily dose range of 12." | 2.66 | Is low-dose hydrochlorothiazide effective? ( Freis, ED; Magee, PF, 1986) |
| "02; 2--A more frequent adjustment of daily dosage with MD (n = 15) than with ACE (n = 10) or LAB (n = 7); 3--The absence of any significant difference for uricemia level, platelet counts, foetal cardiac rythm, and occurrence of pre-eclampsia (MD = 4; ACE = 3; LAB = 4; 4--An equivalent birth-weight (MD = 3110 +/- 628 g; ACE = 3115 +/- 645." | 2.66 | [Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol]. ( Blazquez, G; Gérard, J; Lardoux, H; Leperlier, E, 1988) |
| " Nitrendipine (mean dose 32 mg/day) and acebutolol (414 mg/day) were administered in monotherapy in increasing dosage and mefruside was added in patients not controlled by monotherapy." | 2.66 | Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks. ( Amery, A; Ditu, M; Fagard, R; Lepira, B; Lijnen, P; Lissens, W; M'Buyamba-Kabangu, JR; Staessen, J; Tshiani, KA, 1987) |
| "propranolol retard 160 mg were investigated in a multicentral, double-blind, cross-over study for their action on blood pressure and heart rate in outpatients during ergometer exercise." | 2.66 | Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise. ( Reim, HG; Wagner, W, 1985) |
| "Acebutolol treatment induced reduction in diastolic pressure, heart rate, and PRA pooled from both phases of the study." | 2.65 | Addition of acebutolol to diuretics in hypertension. ( Dziedzic, SW; Elijovich, F; Gorkin, JU; Krakoff, LR, 1981) |
| "5 mg, 25 mg, and 50 mg hydrochlorothiazide combined with 400 mg acebutolol was assessed." | 2.65 | Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker. ( Banks, RA; Bayliss, J; MacGregor, GA; Markandu, ND; Roulston, J, 1983) |
| "Both acebutolol treatments reduced the response; the reduction after twice daily treatment (mean 25 beats/min) was significantly greater than after once daily treatment (mean 19 beats/min)." | 2.65 | Comparison of once and twice daily administration of acebutolol in hypertension. ( Littler, WA; Stallard, TJ; Watson, RD, 1980) |
| "Acebutolol is a relatively "cardioselective" beta-adrenergic blocking agent with an antihypertensive action." | 2.65 | The antihypertensive action of acebutolol. ( Koh, TH; Low, LP, 1981) |
| "Acebutolol appears to be a useful anti-hypertensive in the management of hypertension." | 2.64 | Clinical trial of acebutolol (Sectral) in hypertension. ( Charoenlarp, K; Jaroonvesama, N, 1978) |
| " Optimum dosage defined in an open assessment varied from 200--600 mg twice daily." | 2.64 | Acebutolol in hypertension--double-blind trial against placebo. ( Martin, MA; Phillips, CA; Smith, AJ, 1978) |
| " Dosage can be progressively increased up to 30 mg/day." | 2.64 | [Prazosine: a new vasodilator used for treatment of hypertension (author's transl)]. ( Bret, M; Fillastre, JP; Godin, M, 1978) |
| " Pharmacokinetic data were obtained in hypertensive male patients (4) after treatment with 14C-radioactively labelled acebutolol hydrochloride." | 2.64 | [Pharmacokinetics of acebutolol]. ( Collins, RF, 1975) |
| " The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated." | 2.64 | [Acebutolol in the treatment of arterial hypertension. Clinical study]. ( Chaignon, M; Guédon, J; Lucsko, M, 1975) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 2.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acute myocardial infarction is characterized by a more pronounced rise in plasma ANP concentration in hypertensive patients than in those without a history of hypertension." | 1.29 | Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction. ( Górecki, A; Ignatowska-Switalska, H; Januszewicz, A; Kochanowski, J; Lapiński, M; Opolski, G; Stolarz, P; Słomka, K; Wocial, B, 1995) |
| "Acebutolol was given as a 400-, 600-, or 800-mg single daily dose in the morning." | 1.28 | [Effects of medium-term treatment of acebutolol on lipid profile]. ( Bossini, A; Di Veroli, C, 1990) |
| " There was no correlation between the levels of antinuclear antibodies and the dosage or duration of acebutolol treatment." | 1.27 | [Prevalence of antinuclear antibodies in hypertensive diabetics treated with acebutolol]. ( Abadie, E; Leblanc, H; Lombrail, P; Marre, M; Passa, P, 1984) |
| "Acebutolol has both antihypertensive and antiarrhythmic effects." | 1.27 | Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. ( Abernethy, DR; Arendt, RM; Greenblatt, DJ, 1985) |
| " PRA activity was significantly and markedly reduced by both bunolol and metoprolol shortly after dosing at a time when HR was significantly reduced but MBP was not." | 1.27 | Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. ( Antonaccio, MJ; DeForrest, JM; High, J; Sybertz, E, 1986) |
| ") alone or in combination with furosemide (1 mg/kg, i." | 1.27 | The effects of acebutolol alone and in combination with furosemide or hydralazine in experimentally induced hypertensive G-minipigs. ( Hidaka, H; Sawada, S; Tanioka, Y; Yasuda, Y, 1986) |
| " Evaluation of the iatrogenic risk shows that pharmacologically active amounts of acebutolol might be received by a neonate if the daily maternal dosage exceeds 400 mg/day and/or renal function in the mother is impaired." | 1.27 | To nurse when receiving acebutolol: is it dangerous for the neonate? ( Bianchetti, G; Boutroy, MJ; Dubruc, C; Morselli, PL; Vert, P, 1986) |
| "Acebutolol seemed to cause stroke earlier with the more rapid BP elevation." | 1.26 | Effects of beta-adrenergic blocking drugs in hypertensive rats. ( Shiono, K; Sokabe, H; Sukamoto, T; Watanabe, TX, 1980) |
| " 4 Forearm blood flow, at rest, was significantly reduced at 2 h after dosing with propranolol, but not after acebutolol." | 1.26 | The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. ( Ireland, MA; Littler, WA, 1981) |
| "Acebutolol was compared with oxprenolol in the treatment of 17 CVD patients with hypertension of long standing, 14 of whom had cardiac abnormalities and 16 retired abnormalities." | 1.26 | Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients. ( Almatsier, M; Ranakusuma, TA; Soemargo, S; Tobing, SM, 1981) |
| " The mean daily dosage of diclofurime was 518 mg, the drug being taken in three divided doses." | 1.26 | [Diclofurime, a new major hypotensive agent. Clinical study in 24 patients (author's transl)]. ( Barthes, P; Chevallier, B; Cribier, A; Letac, B, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 227 (82.55) | 18.7374 |
| 1990's | 40 (14.55) | 18.2507 |
| 2000's | 6 (2.18) | 29.6817 |
| 2010's | 1 (0.36) | 24.3611 |
| 2020's | 1 (0.36) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, XY | 1 |
| Soufi, S | 1 |
| Dormuth, C | 1 |
| Musini, VM | 1 |
| Cui, C | 1 |
| Huang, C | 1 |
| Liu, K | 1 |
| Xu, G | 1 |
| Yang, J | 1 |
| Zhou, Y | 1 |
| Feng, Y | 1 |
| Kararigas, G | 1 |
| Geng, B | 1 |
| Cui, Q | 1 |
| Krouf, D | 1 |
| Bouchenak, M | 1 |
| Mohammedi, B | 1 |
| Cherrad, A | 1 |
| Belleville, JL | 1 |
| Prost, JL | 1 |
| Schröder, H | 1 |
| Alekseeva, IuM | 1 |
| Malkina, TA | 1 |
| Sokolov, SF | 1 |
| Franz, IW | 15 |
| Wiewel, D | 2 |
| Bolli, P | 1 |
| Erne, P | 1 |
| Hulthén, UL | 1 |
| Ritz, R | 1 |
| Kiowski, W | 1 |
| Ji, BH | 1 |
| Bühler, FR | 1 |
| Lohmann, FW | 5 |
| Weber, MA | 5 |
| Drayer, JI | 3 |
| Sukamoto, T | 1 |
| Shiono, K | 1 |
| Watanabe, TX | 1 |
| Sokabe, H | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Frick, MH | 1 |
| Kala, R | 1 |
| Gorkin, JU | 1 |
| Elijovich, F | 1 |
| Dziedzic, SW | 1 |
| Krakoff, LR | 1 |
| de Clavière, M | 1 |
| Heyndrickx, JP | 1 |
| Brotelle, R | 1 |
| Colot, M | 1 |
| Thibonnier, M | 2 |
| Flabeau, C | 1 |
| Thouvenin, M | 1 |
| Roux, A | 4 |
| Flouvat, B | 4 |
| Pasquier, P | 1 |
| Menard, J | 12 |
| Dubois, D | 2 |
| Petitcolas, J | 2 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| Whitsett, TL | 1 |
| Levin, DC | 1 |
| Manion, CV | 1 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Horii, M | 1 |
| Yoshii, Y | 1 |
| Hatori, Y | 1 |
| Nakamura, Y | 1 |
| Nemoto, E | 1 |
| Yamato, T | 1 |
| Sakai, T | 1 |
| Yamamoto, Y | 1 |
| Mänttäri, M | 1 |
| Eisalo, A | 1 |
| Koch, G | 4 |
| Quabbe, HJ | 1 |
| Gubba, A | 1 |
| Lil'in, ET | 2 |
| Vavilova, TA | 2 |
| Mar'in, MI | 1 |
| Hagel, F | 2 |
| Ulm, K | 1 |
| Trimarco, B | 1 |
| Ricciardelli, B | 1 |
| De Luca, N | 1 |
| Volpe, M | 1 |
| Veniero, A | 1 |
| Cuocolo, A | 1 |
| Condorelli, M | 1 |
| Mazzaferro, S | 1 |
| Giuliano, G | 1 |
| Lucchini, M | 2 |
| Airoldi, G | 3 |
| Finistauri, D | 1 |
| Massimetti, C | 1 |
| Messa, F | 1 |
| Coen, G | 1 |
| Leblanc, H | 1 |
| Lombrail, P | 1 |
| Marre, M | 1 |
| Abadie, E | 1 |
| Passa, P | 3 |
| Bletry, O | 1 |
| Weiss, Y | 2 |
| Niel, G | 1 |
| Meilhac, B | 1 |
| Chenard, A | 2 |
| Godeau, P | 1 |
| Battaglia, A | 1 |
| Adamo, M | 1 |
| Davi', G | 1 |
| Novo, S | 6 |
| Pinto, A | 4 |
| Custro, N | 1 |
| Averna, M | 1 |
| Mattina, A | 1 |
| Strano, A | 6 |
| Del Nero Júnior, E | 1 |
| Lima, EV | 1 |
| Savioli, RM | 1 |
| de Rezende, MC | 1 |
| Taglioretti, D | 1 |
| Guzzetti, V | 1 |
| Razionale, P | 1 |
| Plouin, PF | 7 |
| Degoulet, P | 3 |
| Fermé, I | 1 |
| Cornette, M | 1 |
| McGowan, GK | 1 |
| Baker, PG | 5 |
| Scotti, A | 1 |
| Lehtonen, A | 4 |
| de Divitiis, O | 2 |
| Petitto, M | 2 |
| Di Somma, S | 2 |
| Fazio, S | 2 |
| Galderisi, M | 2 |
| Villari, B | 1 |
| Liguori, V | 2 |
| Santomauro, M | 1 |
| Sutandar, H | 1 |
| Sugeng, I | 1 |
| Utama, H | 1 |
| Suryaatmaja, M | 1 |
| da Costa, PS | 1 |
| de Moraes, LB | 1 |
| Costa, AG | 1 |
| MacGregor, GA | 2 |
| Banks, RA | 1 |
| Markandu, ND | 2 |
| Bayliss, J | 1 |
| Roulston, J | 1 |
| Ramsay, LE | 2 |
| Schulte, KL | 1 |
| Meyer-Sabellek, W | 1 |
| Gotzen, R | 1 |
| Latini, R | 1 |
| Achilli, L | 1 |
| Lombi, V | 1 |
| Caporicci, D | 1 |
| Hosie, J | 1 |
| Ghafoor, SY | 1 |
| Novaresio, M | 1 |
| Lyall, MG | 1 |
| Bainbridge, JG | 1 |
| Khambatta, RB | 1 |
| Saettone, GP | 1 |
| Cazzani, E | 1 |
| Romanò, M | 1 |
| Muzio, L | 1 |
| Turner, AS | 2 |
| Brocklehurst, JC | 2 |
| Koaté, P | 2 |
| Diouf, S | 2 |
| Sylla, M | 2 |
| Diop, G | 1 |
| Sarr, M | 2 |
| Ba, SA | 1 |
| Williams, ER | 1 |
| Morrissey, JR | 1 |
| Brym, E | 1 |
| Cybulska, I | 1 |
| Czerniewska, E | 1 |
| Watson, RD | 3 |
| Stallard, TJ | 3 |
| Littler, WA | 4 |
| Dumez, Y | 1 |
| Tchobroutsky, C | 1 |
| Hornych, H | 1 |
| Amiel-Tison, C | 1 |
| Henry, JF | 2 |
| Fouache, Y | 1 |
| Chau, NP | 1 |
| Hervy, MP | 2 |
| Forette, F | 2 |
| Bourdarias, JP | 1 |
| Zamotaev, IP | 1 |
| Abramova, VG | 1 |
| Hua, AS | 1 |
| Kalowski, S | 1 |
| Whitworth, JA | 2 |
| Kincaid-Smith, P | 1 |
| Lardoux, MD | 1 |
| Corvol, P | 11 |
| Ongcharit, C | 1 |
| Goulton, J | 4 |
| Richer, C | 1 |
| Venturini-Souto, N | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 1 |
| Nievel, JG | 1 |
| Harvard, CW | 1 |
| Tugaye, A | 2 |
| Gauville, C | 1 |
| Canivet, J | 1 |
| Belleau, LJ | 1 |
| Lebel, M | 1 |
| Brossard, JJ | 3 |
| Bondi, S | 1 |
| Ciglia, C | 1 |
| Mattoscio, N | 1 |
| Leonzio, L | 1 |
| Rossi, A | 2 |
| Mitenko, PA | 1 |
| McKenzie, JK | 1 |
| Rouby, JJ | 1 |
| Gory, G | 1 |
| Bourrelli, B | 1 |
| Glaser, P | 1 |
| Viars, P | 1 |
| Boutroy, MJ | 3 |
| Vert, P | 3 |
| Bianchetti, G | 2 |
| Dubrucq, C | 1 |
| Morselli, PL | 2 |
| Nakashima, M | 1 |
| Kawai, M | 1 |
| Kurasawa, T | 1 |
| Maekawa, N | 1 |
| Kino, T | 1 |
| Mitsuyasu, K | 1 |
| Oshima, S | 1 |
| Accardo, G | 1 |
| Licata, G | 2 |
| Salerno, L | 2 |
| Favi, G | 1 |
| Botindari, G | 1 |
| Avellone, G | 1 |
| Davì, G | 1 |
| Faldetta, E | 1 |
| Guerin, A | 1 |
| Ireland, MA | 1 |
| Low, LP | 1 |
| Koh, TH | 1 |
| Ranakusuma, TA | 1 |
| Tobing, SM | 1 |
| Almatsier, M | 1 |
| Soemargo, S | 1 |
| Darmadji, T | 1 |
| Pikir, BS | 1 |
| Yogiarto, M | 1 |
| Saleh, M | 1 |
| Letac, B | 3 |
| Chevallier, B | 1 |
| Cribier, A | 1 |
| Barthes, P | 1 |
| Nadeau, J | 1 |
| Ogilvie, RI | 1 |
| Ruedy, J | 1 |
| Górecki, A | 1 |
| Januszewicz, A | 1 |
| Opolski, G | 1 |
| Lapiński, M | 1 |
| Wocial, B | 1 |
| Ignatowska-Switalska, H | 1 |
| Słomka, K | 1 |
| Kochanowski, J | 1 |
| Stolarz, P | 1 |
| Parati, G | 2 |
| Mutti, E | 1 |
| Frattola, A | 1 |
| Castiglioni, P | 1 |
| di Rienzo, M | 1 |
| Mancia, G | 2 |
| Yorulmaz, FM | 1 |
| Kuralay, E | 1 |
| Tatar, H | 1 |
| Süer, H | 1 |
| Oztürk, OY | 1 |
| Metelitsa, VI | 1 |
| Duda, SG | 1 |
| Ostrovskaia, TP | 1 |
| Malysheva, NV | 1 |
| Lerman, OV | 1 |
| Shastun, RS | 1 |
| Manoshkina, EM | 1 |
| Piotrovskiĭ, VK | 1 |
| Rumiantsev, DO | 1 |
| Belolipetskaia, VG | 1 |
| Hannedouche, T | 1 |
| Landais, P | 1 |
| Goldfarb, B | 1 |
| el Esper, N | 1 |
| Fournier, A | 3 |
| Godin, M | 2 |
| Durand, D | 1 |
| Chanard, J | 1 |
| Mignon, F | 1 |
| Suo, JM | 1 |
| Filippenko, NG | 1 |
| Povetkin, SV | 2 |
| Smirnova, II | 1 |
| Dementéva, NG | 1 |
| Bredikhin, VT | 1 |
| Sau, F | 3 |
| Seguro, C | 3 |
| Pargentino, E | 1 |
| Widimský, J | 1 |
| Neaton, JD | 1 |
| Grimm, RH | 2 |
| Prineas, RJ | 2 |
| Stamler, J | 1 |
| Grandits, GA | 2 |
| Elmer, PJ | 3 |
| Cutler, JA | 1 |
| Flack, JM | 2 |
| Schoenberger, JA | 1 |
| McDonald, R | 2 |
| Cichocka, E | 1 |
| Januszewicz, P | 1 |
| Wyszynska, T | 1 |
| Stephan, D | 1 |
| Welsch, M | 1 |
| Barthelmebs, M | 1 |
| Imbs, JL | 1 |
| Lewis, CE | 2 |
| Grandits, A | 1 |
| Flack, J | 1 |
| McDonald, RH | 1 |
| Yunis, C | 1 |
| Svendsen, K | 1 |
| Liebson, PR | 1 |
| Alekhin, MN | 1 |
| Sedov, VP | 1 |
| Bozh'ev, AM | 1 |
| Sidorenko, EA | 1 |
| Tomiyama, H | 1 |
| Doba, N | 1 |
| Kushiro, T | 1 |
| Yamashita, M | 1 |
| Yoshida, H | 1 |
| Kanmatsuse, K | 1 |
| Kajiwara, N | 1 |
| Hinohara, S | 1 |
| Azuma, T | 1 |
| Matsubara, T | 1 |
| Nagai, Y | 1 |
| Funauchi, M | 1 |
| Fujimoto, T | 1 |
| Saito, T | 1 |
| Tone, K | 1 |
| Sakoda, S | 1 |
| Greiner, D | 1 |
| Schöfer, H | 1 |
| Milbradt, R | 1 |
| Szymura-Oleksiak, J | 1 |
| Walczak, M | 1 |
| Bojarski, J | 1 |
| Aboul-Enein, HY | 1 |
| Radevski, IV | 1 |
| Valtchanova, SP | 1 |
| Candy, GP | 1 |
| Tshele, EF | 1 |
| Sareli, P | 1 |
| Pieniazek, W | 2 |
| Dimitrow, PP | 1 |
| Jasiński, T | 1 |
| Bouvier, JM | 1 |
| Rabot, D | 1 |
| Herrero, G | 1 |
| Franczuk, P | 1 |
| Janicki, K | 1 |
| Sirotiaková, J | 1 |
| Mlyncek, M | 1 |
| Kriska, M | 1 |
| Letkovicová, M | 1 |
| Zech, P | 1 |
| Pozet, N | 1 |
| Labeeuw, M | 1 |
| Sassard, J | 1 |
| Bernheim, J | 1 |
| Pellet, M | 1 |
| Traeger, J | 1 |
| Bertagna, X | 1 |
| N'Guyen, PT | 1 |
| Guédon, J | 7 |
| Lucsko, M | 6 |
| Chaignon, M | 6 |
| Aubert, Ph | 2 |
| Werning, C | 1 |
| Bouvier, P | 1 |
| Wilcox, RG | 1 |
| Milliez, P | 2 |
| Tannenbaum, H | 1 |
| Emeriau, JP | 1 |
| Rumeau, M | 1 |
| Takami, N | 1 |
| Sugawara, K | 1 |
| Ozaki, M | 1 |
| Wilton, A | 1 |
| Joshi, PI | 1 |
| Ashford, R | 1 |
| Staughton, R | 1 |
| Brighton, WD | 1 |
| Ashton, WL | 2 |
| Scoggins, BA | 1 |
| Allen, KJ | 1 |
| Coghlan, JP | 1 |
| Denton, DA | 1 |
| Graham, WF | 1 |
| Humphery, TJ | 1 |
| Hansson, L | 1 |
| Berglund, G | 1 |
| Andersson, O | 1 |
| Holm, M | 1 |
| Charoenlarp, K | 1 |
| Jaroonvesama, N | 1 |
| Leary, WP | 3 |
| Asmal, AC | 2 |
| Williams, PC | 2 |
| Marwick, B | 2 |
| Martin, MA | 2 |
| Phillips, CA | 1 |
| Smith, AJ | 2 |
| Chatterji, AN | 1 |
| Phillips, FC | 1 |
| Tucker, GT | 1 |
| Fillastre, JP | 4 |
| Bret, M | 1 |
| Fogari, R | 1 |
| Jemoli, R | 1 |
| Del Mastro, S | 1 |
| Sega, R | 1 |
| Comoy, E | 2 |
| Bohuon, C | 1 |
| Forette, B | 1 |
| Berthaux, P | 1 |
| Dreslinski, GR | 1 |
| Aristimuno, GG | 1 |
| Messerli, FH | 1 |
| Suarez, DH | 1 |
| Frohlich, ED | 1 |
| Kreft, C | 1 |
| Montastruc, P | 1 |
| Moreno-González, A | 1 |
| Montastruc, JL | 1 |
| Fah, NT | 1 |
| Bouchez, C | 1 |
| Elaerts, J | 1 |
| Ostermann, G | 1 |
| Hilpert, F | 1 |
| Bajolet, A | 1 |
| Wagner, C | 1 |
| Wolf, LM | 4 |
| Alhenc-Gelas, F | 1 |
| Ducrocq, MB | 2 |
| Lardoux, H | 2 |
| Battino, A | 1 |
| Maurice, P | 2 |
| Girardet, JP | 1 |
| Reumont, G | 1 |
| Houdent, C | 1 |
| Gray, H | 1 |
| Mimran, A | 2 |
| Leckie, BJ | 1 |
| Fourcade, JC | 1 |
| Baldet, P | 1 |
| Navratil, H | 1 |
| Barjon, P | 2 |
| Wee, AS | 1 |
| Collins, RF | 1 |
| Lekieffre, J | 1 |
| Carré, A | 1 |
| Ginestet, A | 1 |
| Dewailly, P | 1 |
| Warembourg, H | 1 |
| Charpentier, A | 1 |
| Wheatley, D | 1 |
| Fourcade, J | 1 |
| Tacquet, A | 1 |
| Bravo, EL | 1 |
| Tarazi, RC | 1 |
| Dustan, HP | 1 |
| Hares, P | 1 |
| James, IM | 1 |
| Griffith, D | 1 |
| Hardin, JM | 2 |
| Alexandre, JM | 2 |
| Lombaert, M | 2 |
| Ronco, G | 2 |
| Bezoc, JF | 2 |
| Quichaud, J | 2 |
| Aubert, P | 2 |
| Tassy, J | 1 |
| Jouve, A | 2 |
| Desmet, G | 1 |
| Safar, M | 1 |
| Kotake, C | 1 |
| Koya, Y | 1 |
| Ikeda, S | 1 |
| Ikeda, Y | 1 |
| Onaka, H | 1 |
| Suyama, K | 1 |
| Ichinohe, T | 1 |
| Hayashi, T | 1 |
| Kawaguchi, K | 1 |
| Seo, T | 1 |
| Yassen, H | 1 |
| Monin, P | 1 |
| Cherchi, A | 2 |
| Yoneda, S | 1 |
| Kako, T | 1 |
| Koketsu, M | 1 |
| Hayano, J | 1 |
| Asakawa, T | 1 |
| Fujinami, T | 1 |
| Kato, T | 1 |
| De Kermadec, JM | 1 |
| Tertrain, F | 1 |
| Abiteboul, M | 1 |
| Abrignani, MG | 1 |
| Liquori, M | 1 |
| Corda, M | 1 |
| Cosentino, F | 1 |
| Jaillon, P | 1 |
| Witkowska, M | 1 |
| Kübler, G | 1 |
| Kopel, E | 1 |
| Karolko, B | 1 |
| Bossini, A | 1 |
| Di Veroli, C | 1 |
| Tönnesmann, U | 3 |
| Behr, U | 3 |
| Ketelhut, R | 3 |
| Pili, G | 1 |
| Basciu, M | 1 |
| Siddi, PP | 1 |
| Tamponi, R | 1 |
| Poncelet, P | 1 |
| Wehrlen, M | 1 |
| Pelletier, B | 1 |
| Capron, MH | 1 |
| Schnaper, HW | 1 |
| Overlack, A | 1 |
| Müller, HM | 1 |
| Kolloch, R | 1 |
| Stumpe, KO | 1 |
| Sivkov, II | 1 |
| Rozinov, IuI | 1 |
| Mamedov, TSh | 1 |
| Gneushev, ET | 1 |
| Alkhazov, AI | 1 |
| Levchuk, VP | 1 |
| Demchenkov, IuIa | 1 |
| Mitrofanov, VA | 1 |
| Confavreux, C | 1 |
| Charles, N | 1 |
| Aimard, G | 1 |
| Neutel, JM | 1 |
| Schnaper, H | 1 |
| Cheung, DG | 1 |
| Graettinger, WF | 1 |
| Grassi, G | 1 |
| Pomidossi, G | 1 |
| Sabadini, E | 1 |
| Giannattasio, C | 1 |
| Bolla, G | 1 |
| Zanchetti, A | 1 |
| Pala, AM | 1 |
| Ricciardelli, D | 1 |
| Sanna, A | 1 |
| Vinattieri, MA | 1 |
| Marino, A | 1 |
| Bianchetti, F | 1 |
| Canel, D | 1 |
| Ziacchi, V | 1 |
| Moretti, L | 1 |
| Lomanto, B | 1 |
| Fracalossi, C | 1 |
| Abernethy, DR | 1 |
| Arendt, RM | 1 |
| Greenblatt, DJ | 1 |
| Ryan, JR | 1 |
| Giacomini, JC | 1 |
| Thoden, WR | 3 |
| Davidov, M | 1 |
| Lewis, JE | 1 |
| Boyles, PW | 1 |
| De Bono, G | 1 |
| Kaye, CM | 1 |
| Roland, E | 1 |
| Summers, AJ | 1 |
| Abengowe, CU | 1 |
| Lewis, RV | 1 |
| Jackson, PR | 1 |
| Belovezhdov, N | 3 |
| Nachev, Ch | 1 |
| Angelova, I | 1 |
| Gergova, V | 1 |
| Stefanov, G | 2 |
| M'Buyamba-Kabangu, JR | 2 |
| Lepira, B | 2 |
| Fagard, R | 2 |
| Lijnen, P | 2 |
| Ditu, M | 2 |
| Tshiani, KA | 2 |
| Amery, A | 2 |
| Antonaccio, MJ | 1 |
| High, J | 1 |
| DeForrest, JM | 1 |
| Sybertz, E | 1 |
| Riant, P | 1 |
| Urien, S | 1 |
| Albengres, E | 1 |
| Duche, JC | 1 |
| Tillement, JP | 1 |
| Gallet, M | 2 |
| Kleinknecht, D | 1 |
| Lestaevel, M | 1 |
| Lopez, M | 1 |
| Manchon, J | 1 |
| Brodsky, D | 1 |
| Mason, DT | 1 |
| Chan, MC | 1 |
| Lee, G | 1 |
| Chatellier, G | 1 |
| Rougeot, MA | 1 |
| Favre, L | 1 |
| Adamec, R | 1 |
| Barthélémy, JC | 1 |
| Loirat, C | 2 |
| Azancot, A | 1 |
| Pillion, G | 1 |
| Macher, MA | 1 |
| Mouchet, B | 1 |
| Gainet, B | 1 |
| Mathieu, H | 1 |
| Vlakhov, N | 1 |
| Terziivanov, D | 2 |
| Koĭchev, A | 1 |
| Vlahov, V | 1 |
| Gerova, Z | 1 |
| Basso, A | 1 |
| Piantanelli, L | 1 |
| Cognini, G | 1 |
| Giunta, S | 1 |
| Andreoni, A | 1 |
| Paciaroni, E | 1 |
| Magee, PF | 1 |
| Freis, ED | 1 |
| Halawa, B | 1 |
| Nakaoka, H | 1 |
| Kitahara, Y | 1 |
| Amano, M | 1 |
| Imataka, K | 1 |
| Fujii, J | 1 |
| Ishibashi, M | 1 |
| Yamaji, T | 1 |
| van den Meiracker, AH | 1 |
| Man in 't Veld, AJ | 1 |
| van Eck, HJ | 1 |
| Boomsma, F | 1 |
| Schalekamp, MA | 1 |
| De Backer, G | 1 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Kocemba, J | 1 |
| Czarnecka, D | 1 |
| Wojciechowska, M | 1 |
| Bes, A | 1 |
| Dupui, P | 1 |
| Guell, A | 1 |
| Géraud, G | 1 |
| Blazquez, G | 1 |
| Leperlier, E | 1 |
| Gérard, J | 1 |
| Ooiwa, H | 1 |
| Shimamoto, K | 1 |
| Nakagawa, M | 1 |
| Iimura, O | 1 |
| Uslenghi, E | 1 |
| Minelli, M | 1 |
| Bo, L | 1 |
| Avogliero, G | 1 |
| Amerio, S | 1 |
| Rocci, R | 1 |
| Borgnino, C | 1 |
| Heebøll-Nielsen, NC | 1 |
| Carlsen, JE | 1 |
| Klimm, HD | 1 |
| Voigt, ED | 1 |
| Wiechmann, HW | 2 |
| Singer, DR | 1 |
| Shore, AC | 1 |
| Piña, IL | 1 |
| Smith, EV | 1 |
| Weidler, DJ | 1 |
| Cavicchi, E | 1 |
| Musacci, GF | 1 |
| Ansani, L | 1 |
| Longhini, C | 1 |
| Román, O | 1 |
| Gac, JG | 1 |
| Basso, B | 1 |
| Pino, ME | 1 |
| Pereda, T | 1 |
| Valenzuela, MA | 1 |
| Wahl, J | 2 |
| Singh, BN | 3 |
| Svendsen, TL | 1 |
| Jelnes, R | 1 |
| Tønnesen, KH | 1 |
| Fraser, DM | 1 |
| Nimmo, GR | 1 |
| Poloniecki, JD | 1 |
| Cowling, CG | 1 |
| Mahomedy, Y | 1 |
| van der Byl, K | 1 |
| Yasuda, Y | 1 |
| Hidaka, H | 1 |
| Sawada, S | 1 |
| Tanioka, Y | 1 |
| Kindermann, W | 1 |
| Widmann, W | 1 |
| Rieder, T | 1 |
| Kullmer, T | 1 |
| Stankusheva, G | 1 |
| Draganov, V | 1 |
| Manolov, P | 1 |
| Levenson, J | 1 |
| Le Quan Sang, KH | 1 |
| Devynck, MA | 1 |
| Gitel, R | 1 |
| Simon, A | 1 |
| Röcker, L | 1 |
| Germanò, G | 1 |
| Ciavarella, M | 1 |
| Ferrucci, A | 1 |
| Lunghi, G | 1 |
| Corsi, V | 1 |
| Kaloianova, A | 1 |
| Nikolov, G | 1 |
| Tsolov, S | 1 |
| Sotirov, I | 1 |
| Tsanov, N | 1 |
| Dubruc, C | 1 |
| Lubis, HR | 1 |
| Silalahi, M | 1 |
| Staessen, J | 1 |
| Lissens, W | 1 |
| de Roquefeuil, F | 1 |
| Goupil, C | 1 |
| Sekine, K | 1 |
| Takahashi, M | 1 |
| Ogata, E | 1 |
| Ohnishi, T | 1 |
| Takase, M | 1 |
| Turlapaty, P | 1 |
| Lejeune, P | 2 |
| Gunselmann, W | 2 |
| Hennies, L | 1 |
| Hess, K | 1 |
| Rittgerodt, K | 1 |
| Winn, K | 1 |
| Gfrerer, G | 2 |
| Schreiber, U | 2 |
| Kerihuel, JC | 2 |
| Ward, A | 1 |
| Salvetti, A | 1 |
| Cagianelli, MA | 1 |
| Cinotti, G | 1 |
| Cortese, R | 1 |
| Diamanti, G | 1 |
| Giuntoli, F | 1 |
| Pedrinelli, R | 1 |
| Pettinà, G | 1 |
| Pandhi, P | 1 |
| Sethi, V | 1 |
| Sharma, BK | 1 |
| Wahl, PL | 1 |
| Sharma, PL | 1 |
| Hoppe, I | 1 |
| Mummel, P | 1 |
| Petersen, B | 1 |
| Winkler, E | 1 |
| Marniemi, J | 1 |
| Niittymäki, K | 1 |
| Serradimigni, A | 1 |
| Perchicot, E | 1 |
| Griener, L | 1 |
| Bénichou, M | 1 |
| Mehta, SK | 1 |
| Goldberg, AD | 1 |
| Walsh, JT | 1 |
| Napier, RN | 1 |
| Mühlberg, W | 1 |
| Platt, D | 1 |
| Mutschler, E | 1 |
| Möhrke, W | 1 |
| Raineri, A | 1 |
| Immordino, R | 1 |
| Giannola, A | 1 |
| Indovina, G | 1 |
| Reim, HG | 1 |
| Wagner, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000522] | Phase 2 | 0 participants | Interventional | 1985-08-31 | Completed | ||
| Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients[NCT03738761] | Phase 4 | 471 participants (Actual) | Interventional | 2018-02-13 | Completed | ||
| Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction[NCT00382161] | Phase 3 | 20 participants (Anticipated) | Interventional | 2006-10-31 | Withdrawn (stopped due to not enough patients meeting inclusion criteria) | ||
| Effect of Combined Antihypertensive Therapy on Blood Pressure and Sexual Function in Patients With Essential Hypertension[NCT01238705] | Phase 4 | 280 participants (Anticipated) | Interventional | 2008-04-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for acebutolol and Hypertension
| Article | Year |
|---|---|
Time course for blood pressure lowering of beta-blockers with partial agonist activity.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; B | 2020 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty A | 1983 |
[Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Humans; Hypertensio | 1983 |
[Incidence of beta-blockers on plasma renin activity. Present status].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aldosterone; Blood Pressure; Depression, Chemical; Dose-Res | 1978 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Toleranc | 1978 |
Relevance of intrinsic sympathomimetic activity for beta blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Circulation; Cardiac Output; Catecholamines; | 1990 |
Documentation of the effective length of action of antihypertensive treatment.
Topics: Acebutolol; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; | 1990 |
Acebutolol effects on lipid profile.
Topics: Acebutolol; Alcohol Drinking; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, | 1990 |
Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Topics: Acebutolol; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cholesterol, HDL; Humans; Hyp | 1985 |
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cardiovascular Physiological Phenomena; Cardiovasc | 1986 |
Acebutolol: ten years of experience.
Topics: Acebutolol; Adrenergic beta-Antagonists; Age Factors; Animals; Arrhythmias, Cardiac; Blood Circulati | 1985 |
Antihypertensive therapy and the concept of total cardiovascular protection.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; | 1987 |
[Arterial hypertension in the newborn infant. Etiologies. Treatment].
Topics: Acebutolol; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Endoc | 1988 |
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Topics: Acebutolol; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Vessels; B | 1985 |
136 trials available for acebutolol and Hypertension
| Article | Year |
|---|---|
Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Algeria; Antihypertensive Agents; Antioxidants; Apol | 2003 |
[Interrelationship between changes of rate and variability of cardiac rhythm under influence of beta-adrenoblockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Dose-Response Relationsh | 2007 |
Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Chol | 1984 |
[Differential effect of long-term beta1-selective and nonselective beta-receptor blockade on carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Blood Glucose; Blood Pr | 1980 |
Addition of acebutolol to diuretics in hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diur | 1981 |
Antihypertensive effect of diacetolol in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose | 1982 |
A comparison of two cardioselective beta-blockers with different ancillary properties in the treatment of hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Femal | 1982 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty A | 1983 |
beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Catecholamines; Hemodynamics; Humans; | 1983 |
[Effect of 8 week beta blocker therapy on parameters of circulation and lipid metabolism].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Circulation; Humans; Hypertension; Lipid Metabolism; | 1983 |
Single-agent and combination therapy of essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Diuretics; Drug Therapy | 1984 |
[Acebutolol: experience with its use in ambulatory management of arterial hypertension].
Topics: Acebutolol; Aged; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged | 1983 |
[Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Fema | 1983 |
[Acebutolol in arterial hypertension: clinical evaluation].
Topics: Acebutolol; Clinical Trials as Topic; Humans; Hypertension | 1983 |
Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance.
Topics: Acebutolol; Adult; Blood Pressure; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Th | 1983 |
[Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
Topics: Acebutolol; Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Exercise Tes | 1984 |
Treatment of essential hypertension with beta-blocker plus diuretic: a study of 1402 patients treated by general practitioners with acebutolol 200 mg combined with hydrochlorothiazide 12.5 mg ('Secadrex') once daily for 3 months.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Dru | 1984 |
[Controlled clinical study on the effects of acebutolol in comparison with hydrochlorothiazide in the aged hypertensive].
Topics: Acebutolol; Aged; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hydrochlorothiazide; | 1983 |
Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability.
Topics: Acebutolol; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Interactions; Drug Therapy, C | 1984 |
The efficacy and acceptability of the combination of acebutolol and hydrochlorothiazide in the treatment of essential hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Female; Humans | 1984 |
[Comparison of the anti-hypertensive effects of combinations of nifedipine retard with acebutolol or atenolol].
Topics: Acebutolol; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Fe | 1984 |
Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.
Topics: Acebutolol; Adult; Body Weight; Chlorides; Clinical Trials as Topic; Dose-Response Relationship, Dru | 1983 |
Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension.
Topics: Acebutolol; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middl | 1983 |
[Evaluation of the hypotensive effect of acebutolol (Sectral)].
Topics: Acebutolol; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind M | 1982 |
Comparison of once and twice daily administration of acebutolol in hypertension.
Topics: Acebutolol; Adult; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Heart | 1980 |
Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise.
Topics: Acebutolol; Adult; Blood Glucose; Dopamine; Epinephrine; Humans; Hypertension; Lipids; Long-Term Car | 1981 |
Acebutolol in mild to moderate hypertension: a double-blind crossover study.
Topics: Acebutolol; Chlorothiazide; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertens | 1980 |
Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
Topics: Acebutolol; Adult; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Ethanolamines | 1980 |
An open study of acebutolol, given as a single daily dose in the management of hypertension in the Chulalungkorn Hospital, Thailand.
Topics: Acebutolol; Administration, Oral; Adult; Clinical Trials as Topic; Female; Humans; Hypertension; Mal | 1980 |
Assessment of the efficacy and acceptability of an acebutolol/hydrochlorothiazide combination in the treatment of mild to moderate essential hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Female; Heart | 1981 |
Merits of adding a beta blocker (acebutolol) to a diuretic (hydrochlorothiazide) in the treatment of hypertension.
Topics: Acebutolol; Adult; Aldosterone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combina | 1982 |
Antihypertensive action of acebutolol (Sectral) when used concomitantly with hydrochlorothiazide.
Topics: Acebutolol; Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Heart Rate; H | 1982 |
[Comparative studies with beta blockers in hypertensive patients in ambulatory care].
Topics: Acebutolol; Adolescent; Adult; Ambulatory Care; Female; Humans; Hypertension; Hypertension, Renal; M | 1982 |
[The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
Topics: Acebutolol; Adolescent; Adult; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Heart R | 1982 |
The antihypertensive action of acebutolol.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; | 1981 |
Beneficial effects of beta-adrenergic blockade in coronary artery surgery: clinical research.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiotonic Agents; Coronary A | 1993 |
[Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
Topics: Acebutolol; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Hemodynamics; H | 1993 |
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.
Topics: Acebutolol; Adolescent; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Enalapril; Female; Human | 1994 |
[Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Lipid Peroxidation; Male; Middle Aged; Penb | 1993 |
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Diastole; Double-Blind Method | 1993 |
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Diastole; Double-Blind Method | 1993 |
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Diastole; Double-Blind Method | 1993 |
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Diastole; Double-Blind Method | 1993 |
[Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents].
Topics: Acebutolol; Adolescent; Blood Glucose; Blood Pressure; Cholesterol, LDL; Clinical Protocols; Female; | 1993 |
[Ambulatory or single measurement of blood pressure: comparison in a controlled trial in patients with hypertension].
Topics: Acebutolol; Adult; Ambulatory Care; Blood Pressure Determination; Clinical Protocols; Double-Blind M | 1993 |
Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study.
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Doxazosin; Enalapril; Female; | 1996 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosi | 1997 |
Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction.
Topics: Acebutolol; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Ca | 1997 |
Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Black People; Blood Pressure; Carb | 1999 |
Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular C | 2001 |
Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Chi-Sq | 1990 |
[The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypert | 2001 |
[Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents].
Topics: Acebutolol; Adolescent; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Pregnancy; Pre | 2002 |
Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Pressure; Depression, Chemical; Female; Heart | 1976 |
[Effects of new beta receptor blocking agent Acebutolol in patients with essential, renal, and broderline hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Female; Hemodynamics; Huma | 1977 |
[Can one give beta-blockers to diabetics? How does one treat a hypertensive diabetic?].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Co | 1978 |
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as To | 1978 |
An open, multicentre study of acebutolol, given as a single daily dose, in the management of hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Family Practice; Female; Heart Rate; Humans; Hypertension; | 1977 |
Controlled trial of acebutolol in hypertension.
Topics: Acebutolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Hyper | 1977 |
Clinical trial of acebutolol (Sectral) in hypertension.
Topics: Acebutolol; Adult; Aged; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combi | 1978 |
Treatment of hypertension with single daily doses of acebutolol.
Topics: Acebutolol; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; | 1978 |
Acebutolol in hypertension--double-blind trial against placebo.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Echocardiogr | 1978 |
A randomized crossover comparison of acebutolol and methyldopa in the treatment of mild to moderate essential hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Mal | 1978 |
Acebutolol in hypertension: relationships between drug concentration and effects.
Topics: Acebutolol; Acetylation; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Femal | 1978 |
Aldactone and acebutolol in treatment of hypertension.
Topics: Acebutolol; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Male; | 1979 |
[Prazosine: a new vasodilator used for treatment of hypertension (author's transl)].
Topics: Acebutolol; Adult; Aged; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Dru | 1978 |
A multicentre study of twice daily acebutolol ('Sectral') in the treatment of hypertension in general practice.
Topics: Acebutolol; Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Administration S | 1979 |
[Long term treatment with acebutolol in hypertension (author's transl)].
Topics: Acebutolol; Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Femal | 1979 |
[The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)].
Topics: Acebutolol; Aged; Canrenone; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Huma | 1979 |
[Pharmacokinetics of acebutolol].
Topics: Acebutolol; Animals; Autoradiography; Clinical Trials as Topic; Half-Life; Humans; Hypertension; Mal | 1975 |
[Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension].
Topics: Acebutolol; Adult; Blood Circulation; Blood Pressure; Clinical Trials as Topic; Drug Tolerance; Fema | 1975 |
[Acebutolol test in moderate arterial hypertension. Action on systolic time intervals].
Topics: Acebutolol; Adult; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hypertension; Middl | 1975 |
[Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension].
Topics: Acebutolol; Anxiety; Bendroflumethiazide; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1975 |
[Results of the treatment of essential arterial hypertension following prolonged (24 months administration of acebutolol)].
Topics: Acebutolol; Adolescent; Adult; Age Factors; Clinical Trials as Topic; Female; Humans; Hypertension; | 1975 |
[Acebutolol in the treatment of arterial hypertension. Clinical study].
Topics: Acebutolol; Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combin | 1975 |
[Treatment of arterial hypertension with acebutolol. Clinical results].
Topics: Acebutolol; Autonomic Nervous System; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; | 1975 |
[Comparative study of acebutolol and propranolol in the treatment of arterial hypertension].
Topics: Acebutolol; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Ma | 1975 |
A new beta-adrenergic blocking drug in hypertension. A report from the General Practitioner Research Group.
Topics: Acebutolol; Bendroflumethiazide; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans | 1976 |
[Test with trinitrine. Clinical evaluation of the beta anti-adrenergic effect of acebutolol in arterial hypertension].
Topics: Acebutolol; Adult; Clinical Trials as Topic; Drug Evaluation; Female; Heart Rate; Humans; Hypertensi | 1975 |
An open, multicentre study of acebutolol in hypertension.
Topics: Acebutolol; Adult; Aged; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Time Fact | 1976 |
[Treatment of arterial hypertension with acebutolol. Double-blind study with placebos].
Topics: Acebutolol; Adolescent; Adult; Blood Pressure; Drug Evaluation; Drug Tolerance; Female; Heart Rate; | 1975 |
Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aldosterone; Benzothiadiazines; Blood Pressure; Captopril; | 1991 |
Maintenance of blood pressure control in elderly hypertensives on ketoprofen.
Topics: Acebutolol; Aged; Aged, 80 and over; Aging; Atenolol; Blood Pressure; Double-Blind Method; Drug Ther | 1991 |
Regression of structural vascular changes after chronic treatment in hypertensives.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Captopril; Female; Hemodynamics; Humans; Hypertension; Labe | 1991 |
[Comparative effectiveness of various beta adrenergic blockaders in hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propranolol | 1991 |
[Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Female; Gallopamil; Humans; Hype | 1990 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
Spironolactone and altizide used in combination with enalapril: twenty-four-hour ambulatory recording of blood pressure.
Topics: Acebutolol; Benzothiadiazines; Blood Pressure; Diuretics; Drug Therapy, Combination; Enalapril; Fema | 1990 |
Acebutolol effects on lipid profile.
Topics: Acebutolol; Alcohol Drinking; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, | 1990 |
[Therapy of moderate hypertension with the calcium antagonist nitrendipine in combination with beta receptor blocker or diuretic].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Hum | 1990 |
Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements.
Topics: Acebutolol; Adult; Aged; Atenolol; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Female | 1990 |
[Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Cardiac Volume; Cardiomegaly; | 1989 |
[The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrocardiography; Female; Humans; | 1989 |
[Enalapril and acebutolol in essential arterial hypertension. Comparison of the 2 drugs and evaluation of their combination].
Topics: Acebutolol; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Exercise; Female; | 1988 |
Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Clinical Trials as Topic; Double- | 1985 |
Comparison of acebutolol and hydrochlorothiazide in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Female; Humans; Hydrochlo | 1985 |
Once-daily administration of acebutolol in treatment of hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Humans; Hypertension; Middle Aged; Placebos | 1985 |
Effects of age and race on clinical response to acebutolol in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Black People; Clinical Trials as | 1985 |
A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Black People; Blood Pressure; Body Weight; Dos | 1985 |
[Clinical studies of celiprolol in the treatment of arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Clinical Trials as Topic; Double-B | 1985 |
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Black or | 1986 |
Antihypertensive effects of tertatolol: 3-month comparative study against acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Female; Heart Rate | 1986 |
[Comparative study of the effectiveness and acceptability of tertatolol 5 mg and acebutolol 400mg in the treatment of mild arterial hypertension].
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Antihypertensive Agents; Clinical Tri | 1987 |
Antihypertensive therapy and the concept of total cardiovascular protection.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; | 1987 |
[Nyctohemeral blood pressure profiling by automatic measurement in ambulatory hypertensive patients. Treatment with acebutolol].
Topics: Acebutolol; Adult; Ambulatory Care; Blood Pressure Determination; Circadian Rhythm; Female; Humans; | 1986 |
[Plasma levels and the antihypertensive effect of the preparation celiprolol].
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Celiprolol; Drug Evaluation; Female; Humans; Hyper | 1986 |
Comparison of the antihypertensive effects of celiprolol and acebutolol.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Blood Pressure; Celiprolol; Clinical Trials as Top | 1988 |
Is low-dose hydrochlorothiazide effective?
Topics: Acebutolol; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enala | 1986 |
Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension.
Topics: Acebutolol; Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Drug Adm | 1988 |
[Comparative effects of metoprolol and acebutolol in primary arterial hypertension].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Mal | 1988 |
[Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol].
Topics: Acebutolol; Adult; Female; Heart Rate, Fetal; Humans; Hypertension; Hypoglycemia; Infant, Newborn; L | 1988 |
[Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients].
Topics: Acebutolol; Adult; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Exercise Test | 1985 |
[A randomized comparison between acebutolol and metoprolol in 215 patients with hypertension. Significance of the self-stimulating effect and awareness of the occurrence of adverse effects].
Topics: Acebutolol; Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; | 1988 |
[Antihypertensive therapy in young hypertensive patients. Effect of tredalat in comparison with adalat on blood pressure behavior and metabolism, especially renin excretion].
Topics: Acebutolol; Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dr | 1988 |
[Hemodynamic effects of different antihypertensive combinations].
Topics: Acebutolol; Antihypertensive Agents; Captopril; Chronic Disease; Diuretics; Drug Evaluation; Drug Th | 1988 |
Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension.
Topics: Acebutolol; Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hype | 1987 |
Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
Topics: Acebutolol; Adult; Aged; Aged, 80 and over; Angina Pectoris; Electrocardiography; Female; Humans; Hy | 1988 |
[Comparative evaluation of the antihypertensive action of nitrendipine and indapamide].
Topics: Acebutolol; Aged; Antihypertensive Agents; Diuretics; Drug Evaluation; Drug Therapy, Combination; Fe | 1987 |
Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hear | 1986 |
The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication.
Topics: Acebutolol; Aged; Blood Pressure; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypertensi | 1986 |
Acebutolol in the treatment of diabetic patients with hypertension.
Topics: Acebutolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Diabete | 1986 |
Antihypertensive effects of acebutolol plus hydrochlorothiazide and hydrochlorothiazide alone in black patients.
Topics: Acebutolol; Adult; Black People; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; H | 1986 |
[Physical performance in antihypertensive therapy. Results of a calcium antagonist-beta blocker combination].
Topics: Acebutolol; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Exercise Test; | 1987 |
[Modification of resting and effort hemodynamics in essential arterial hypertension using antihypertensive agents].
Topics: Acebutolol; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; | 1987 |
Effect of chronic beta-adrenergic blockade on exercise-induced leukocytosis.
Topics: Acebutolol; Adult; Humans; Hypertension; Leukocyte Count; Leukocytosis; Lymphocytes; Male; Neutrophi | 1986 |
A comparative study of two beta-blocker-diuretic combinations in the treatment of hypertension.
Topics: Acebutolol; Adult; Aged; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertensio | 1986 |
Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks.
Topics: Acebutolol; Adolescent; Adult; Aged; Black or African American; Body Weight; Double-Blind Method; Dr | 1987 |
Comparison of acebutolol and propranolol in essential hypertension.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Blood Pressure; Body Weight; Clinical Trials as To | 1985 |
Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine.
Topics: Acebutolol; Adult; Age Factors; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; | 1985 |
Proceedings of the symposium on improved beta-adrenergic blockade therapy: results of acebutolol trials. June 1-2, 1984, Monterey, California.
Topics: Acebutolol; Clinical Trials as Topic; Humans; Hypertension | 1985 |
Comparative study of muzolimine and acebutolol in the treatment of moderate hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; | 1985 |
Acebutolol.
Topics: Acebutolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Ventricles; Humans; Hypertension; | 1985 |
Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly.
Topics: Acebutolol; Aged; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hydrochlorothiazide; | 1985 |
Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
Topics: Acebutolol; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension | 1985 |
Effects of a fixed combination of low dose nifedipine and acebutolol on essential hypertension: comparison with standard dose acebutolol.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1985 |
[Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; | 1985 |
Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison.
Topics: Acebutolol; Adult; Aged; Atenolol; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Ma | 1985 |
Ambulatory BP monitoring after acute administration of slow release nifedipine, alone or in combination with acebutolol, in systo-diastolic and in systolic hypertension.
Topics: Acebutolol; Adult; Aged; Ambulatory Care; Blood Pressure; Blood Pressure Determination; Humans; Hype | 1985 |
Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
Topics: Acebutolol; Adolescent; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hyper | 1985 |
127 other studies available for acebutolol and Hypertension
| Article | Year |
|---|---|
Large-scale in silico identification of drugs exerting sex-specific effects in the heart.
Topics: Acebutolol; Animals; Blood Pressure; China; Computer Simulation; Drug Therapy; Female; Heart; Heart | 2018 |
[Antihypertensive therapy with left cardiac insufficiency].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Platelets; Blood Pressure; Calcium; Calc | 1984 |
Differential antihypertensive effect of acebutolol and hydrochlorothiazide/amiloride hydrochloride combination on elevated exercise blood pressures in hypertensive patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Amiloride; Antihypertensive Agents; Blood Pressure; | 1980 |
Renal effects of beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Blood Pressure; Cardia | 1980 |
Effects of beta-adrenergic blocking drugs in hypertensive rats.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cerebrovascular Disorders; Hypertension; Kidney; M | 1980 |
Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Blood Pressure; Double-Blind M | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relation | 1980 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Double-Blind Method; Forced Expiratory Flow | 1982 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Me | 1983 |
Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.
Topics: Acebutolol; Adult; Cardiomegaly; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; H | 1984 |
[Acebutolol as monotherapy of essential arterial hypertension].
Topics: Acebutolol; Adult; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hypertension; Male | 1984 |
[Prevalence of antinuclear antibodies in hypertensive diabetics treated with acebutolol].
Topics: Acebutolol; Adolescent; Adult; Aged; Antibodies, Antinuclear; Diabetes Complications; Diabetes Melli | 1984 |
[Incidence of antinuclear antibodies during treatment with acebutolol. A 1-year prospective study in 45 hypertensive patients treated by monotherapy].
Topics: Acebutolol; Adult; Antibodies, Antinuclear; Female; Humans; Hypertension; Male; Middle Aged; Prospec | 1984 |
Platelet activation after adrenergic stimulation in hypertensive patients: effects of acebutolol.
Topics: Acebutolol; Adult; Blood Pressure; Cold Temperature; Epoprostenol; Female; Heart Rate; Humans; Hyper | 1983 |
The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels.
Topics: Acebutolol; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; | 1984 |
Beta blockers and flat dose response to thiazide in hypertension.
Topics: Acebutolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide | 1983 |
Effects of acebutolol combined with mefruside on total-body and serum potassium in essential hypertensive patients.
Topics: Acebutolol; Adult; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertensio | 1984 |
[Efficacy of acebutolol in hypertensive and arrhythmia patients].
Topics: Acebutolol; Adult; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Hypertension; Male; Middle | 1984 |
Ocular, systemic and antinuclear antibody changes with acebutolol.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Eye Diseases; Female; Humans; Hypertension; Male; | 1983 |
[The exercise test in supervision of the effectiveness of acebutolol administration in hypertensive patients].
Topics: Acebutolol; Adult; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged | 1983 |
Ophthalmological monitoring of patients receiving long-term acebutolol.
Topics: Acebutolol; Eye; Humans; Hypertension; Monitoring, Physiologic | 1983 |
[Treatment of essential arterial hypertension with a single daily dose of acebutolol].
Topics: Acebutolol; Drug Administration Schedule; Female; Headache; Heartburn; Humans; Hypertension; Hypoten | 1983 |
[Hypertension treatment: weight reduction training or drugs?].
Topics: Acebutolol; Adolescent; Adult; Blood Pressure; Diet, Reducing; Diuretics; Female; Humans; Hypertensi | 1983 |
[The use of acebutolol in arterial hypertension. Apropos of 31 case records of Senegalese patients].
Topics: Acebutolol; Adult; Age Factors; Aged; Female; Humans; Hypertension; Male; Middle Aged; Senegal; Sex | 1983 |
A comparison of acebutolol with methyldopa in hypertensive pregnancy.
Topics: Acebutolol; Adult; Apgar Score; Birth Weight; Blood Pressure; Female; Humans; Hypertension; Infant, | 1983 |
Neonatal effects of maternal administration of acebutolol.
Topics: Acebutolol; Blood Glucose; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Infant, Newborn | 1981 |
A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Female; Half-Life; Humans; Hypertension; Injections, | 1983 |
[Significance of the strength of the central nervous system in the variability of reactions to acebutolol].
Topics: Acebutolol; Adult; Antihypertensive Agents; Attention; Flicker Fusion; Humans; Hypertension; Middle | 1983 |
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hype | 1980 |
Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.
Topics: Acebutolol; Blood Pressure; Diabetes Complications; Female; Heart Rate; Humans; Hypertension; Male; | 1981 |
[Acebutolol in the treatment of stress-reactive hypertension. A medium term open study].
Topics: Acebutolol; Adult; Aged; Electrocardiography; Exercise Test; Humans; Hypertension; Male; Middle Aged | 1982 |
Resistance to sodium nitroprusside in hypertensive patients.
Topics: Acebutolol; Acute Disease; Adult; Aged; Child; Drug Resistance; Female; Ferricyanides; Humans; Hyper | 1982 |
Infants born to hypertensive mothers treated by acebutolol. Pharmacological studies in the perinatal period.
Topics: Acebutolol; Adult; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Kine | 1982 |
[The effect of acebutolol, beta 1-selective blocker, on patients with essential hypertension and asthma].
Topics: Acebutolol; Adult; Aged; Asthma; Female; Humans; Hypertension; Male; Middle Aged | 1982 |
[New therapeutic approach to arterial hypertension using acebutolol].
Topics: Acebutolol; Adult; Aged; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged | 1982 |
[Effects of a nifedipine-acebutolol combination in the treatment of patients with essential arterial hypertension].
Topics: Acebutolol; Adult; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Midd | 1982 |
[The use of acebutolol in arterial hypertension. Apropos of 13 records of Senegalese patients].
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Evaluation; Drug T | 1982 |
[Hemodynamic effects and effects on the renin-angiotensin-aldosterone system of the combination of nifedipine and acebutolol in patients with essential hypertension].
Topics: Acebutolol; Adult; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Midd | 1981 |
Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64-years' old and over 65 years' old age groups.
Topics: Acebutolol; Aged; Aging; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pulse; Tim | 1981 |
The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients.
Topics: Acebutolol; Administration, Oral; Adult; Blood Pressure; Female; Forearm; Heart Rate; Humans; Hypert | 1981 |
Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Central Nervous System; Cerebrovascular Disorders; | 1981 |
The use of acebutolol with hydrochlorothiazide in hypertension.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; | 1981 |
[Diclofurime, a new major hypotensive agent. Clinical study in 24 patients (author's transl)].
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Furans; Humans; | 1980 |
Acebutolol and hydrochlorothiazide in essential hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hydrochlor | 1980 |
Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
Topics: Acebutolol; Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Creatine Ki | 1995 |
Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Baroreflex; Blood Pressure; Circadian Rhythm; Female | 1994 |
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Echocardi | 1994 |
[Acebutolol in the therapy of mild and moderate hypertension].
Topics: Acebutolol; Adolescent; Adult; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged | 1994 |
[Doppler echocardiography in assessing the effect of the beta 1-selective adrenoblocker acebutolol on left-ventricular diastolic filling in hypertension patients].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Diastole; Drug Evaluation; Echocardiography, Doppler | 1997 |
Effects of long-term antihypertensive therapy on physical fitness of men with mild hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Drug Thera | 1997 |
Reversible transverse overcurvature of the nails (pincer nails) after treatment with a beta-blocker.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Humans; Hypertension; Male; | 1998 |
Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
Topics: Acebutolol; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Hypertension; Ind | 1999 |
Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aminohippuric Acids; Atenolol; Chlorides; Glomerular Filtra | 1976 |
[Indications and limits for the use of beta-blockaders (beta-adrenergic inhibitors) in the treatment of hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Humans; Hypertension; Propranol | 1977 |
[Beta-blockers and arterial hypertension in the aged patient].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Electrocardiography; Female; Heart Rate; Humans; Hype | 1978 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnanc | 1978 |
Effects of beta-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man.
Topics: Acebutolol; Adolescent; Adrenergic beta-Agonists; Adult; Aging; Blood Pressure; Female; Heart Rate; | 1979 |
[Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Female; Hear | 1979 |
Adrenergic receptors and renin release.
Topics: Acebutolol; Angiotensin II; Humans; Hypertension; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1977 |
Cutaneous vasculitis due to acebutolol.
Topics: Acebutolol; Drug Hypersensitivity; Female; Humans; Hypertension; Male; Middle Aged; Vascular Disease | 1977 |
Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.
Topics: Acebutolol; Activities of Daily Living; Adolescent; Adult; Bed Rest; Blood Pressure; Circadian Rhyth | 1979 |
Haemodynamics of ACTH-induced hypertension in sheep.
Topics: Acebutolol; Adrenocorticotropic Hormone; Animals; Blood Pressure; Cardiac Output; Disease Models, An | 1979 |
A multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Diuretics; Female; Humans; Hypertension; Male; Middle | 1979 |
[Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Norepineph | 1979 |
Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume.
Topics: Acebutolol; Adult; Blood Pressure; Cardiac Output; Female; Humans; Hypertension; Kidney; Male; Middl | 1979 |
Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
Topics: Acebutolol; Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Diet; Heart Rate; Humans | 1979 |
Experimental studies on the anti-hypertensive effect of acebutolol in dogs: further evidence for a central site of action.
Topics: Acebutolol; Animals; Antihypertensive Agents; Dogs; Drug Evaluation, Preclinical; Female; Hypertensi | 1978 |
Treatment of hypertension with acebutolol.
Topics: Acebutolol; Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged | 1977 |
[Antihypertensive action of acetbutolol. Pharmacokinetic correlation and medium-term fate].
Topics: Acebutolol; Antihypertensive Agents; Blood Pressure; Drug Evaluation; Humans; Hypertension; Time Fac | 1978 |
[Prolonged treatment with acebutolol: surveilance of ocular status (author's transl)].
Topics: Acebutolol; Adult; Eye; Female; Fluorescein Angiography; Humans; Hypertension; Male; Middle Aged; Op | 1978 |
Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension.
Topics: Acebutolol; Adult; Aldosterone; Amiloride; Blood Pressure; Dose-Response Relationship, Drug; Drug Th | 1978 |
[Action of beta blockaders in hypertension caused by isthmic aortic coarctation: a new proof in favor of renin-angiotensin system].
Topics: Acebutolol; Adolescent; Adult; Angiotensin II; Aortic Coarctation; Child; Female; Humans; Hypertensi | 1978 |
[Artefact during the estimation of 17-ketosteroids in patients treated with acebutolol (author's transl)].
Topics: 17-Ketosteroids; Acebutolol; Chromatography, Gas; Colorimetry; Humans; Hypertension | 1978 |
Blood pressure, renin-angiotensin system and urinary kallikrein in a case of juxtaglomerular cell tumor.
Topics: Acebutolol; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Half-Life; Humans; Hypertens | 1978 |
Hypertension treated with acebutolol.
Topics: Acebutolol; Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged | 1978 |
Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.
Topics: Acebutolol; Aldosterone; Animals; Chronic Disease; Clonidine; Corticosterone; Diet, Sodium-Restricte | 1977 |
The effect of acebutolol on the cerebral circulation of man.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Carbon Dioxide; Cerebrovascular Circulation; Heart Rate; Hu | 1977 |
Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man.
Topics: Acebutolol; Adult; Aldosterone; Angiotensins; Diet, Sodium-Restricted; Humans; Hypertension; Male; M | 1977 |
[Antihypertensive effect and inhibition of the sympathetic nervous system by acebutolol].
Topics: Acebutolol; Adult; Antihypertensive Agents; Depression, Chemical; Drug Evaluation; Female; Heart Rat | 1976 |
[Pharmacokinetics of acebutolol in renal failure].
Topics: Acebutolol; Humans; Hypertension; Kidney Failure, Chronic; Kinetics; Renal Dialysis | 1976 |
[Acebutolol in the treatment of arterial hypertension].
Topics: Acebutolol; Adult; Aged; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged | 1976 |
Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities.
Topics: Acebutolol; Adult; Catecholamines; Dopamine beta-Hydroxylase; Female; Humans; Hypertension; Male; Mi | 1976 |
[Acebutolol in arterial hypertension. Hemodynamic effects and effects on plasma renin].
Topics: Acebutolol; Administration, Oral; Adult; Blood Pressure; Drug Tolerance; Hemodynamics; Humans; Hyper | 1975 |
[Study of acebutolol dialysis and pharmacokinetic data in patients with renal insufficiency undergoing hemodialysis].
Topics: Acebutolol; Acute Kidney Injury; Half-Life; Humans; Hypertension; In Vitro Techniques; Kidney; Metab | 1975 |
[Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension].
Topics: Acebutolol; Adolescent; Adult; Aldosterone; Blood Pressure; Diet, Sodium-Restricted; Humans; Hyperte | 1975 |
[Acebutolol in arterial hypertension. Conclusions].
Topics: Acebutolol; Blood Pressure; Drug Tolerance; Heart Rate; Humans; Hypertension | 1975 |
[Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Humans; Hypertension; Hypertrophy, Left Ven | 1992 |
[The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Female; Humans; | 1992 |
[Hemodynamic and renal adaptation of newborn infants of hypertensive mothers treated with acebutolol].
Topics: Acebutolol; Diuresis; Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Kidney; Pregnancy | 1992 |
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocard | 1991 |
[Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?].
Topics: Acebutolol; Adult; Coronary Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male | 1991 |
[Effects of medium-term treatment of acebutolol on lipid profile].
Topics: Acebutolol; Adult; Female; Humans; Hypertension; Lipids; Male; Middle Aged | 1990 |
[Comparative effectiveness of propranolol and acebutolol in arterial hypertension].
Topics: Acebutolol; Adult; Aged; Drug Evaluation; Humans; Hypertension; Middle Aged; Propranolol; Time Facto | 1990 |
Fulminant myasthenia gravis soon after initiation of acebutolol therapy.
Topics: Acebutolol; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Electromyography; | 1990 |
Regression of left ventricular hypertrophy by acebutolol and nifedipine.
Topics: Acebutolol; Blood Pressure; Cardiomegaly; Drug Combinations; Echocardiography; Humans; Hypertension; | 1989 |
Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood-Brain Barrier; Cats; C | 1985 |
Clinical pharmacology of acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Digoxin; Drug Interactions; Female; Humans; Hy | 1985 |
Ancillary pharmacologic properties of acebutolol: cardioselectivity, partial agonist activity, and membrane-stabilizing activity.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Asthma; Bronchi; Cell Membrane; H | 1985 |
Effect of beta blockers on blood lipid profile.
Topics: Acebutolol; Adrenergic beta-Antagonists; Apolipoproteins; Cholesterol; Cholesterol, HDL; Humans; Hyp | 1985 |
Oxygen uptake and plasma catecholamines during submaximal and maximal exercise after long-term beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Catecholamines; Dopamine; Epinephrine; Heart Rate; H | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hy | 1985 |
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Decerebrate St | 1986 |
High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Female; Humans; Hypertension; Lactation; Mi | 1986 |
Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition.
Topics: Acebutolol; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzy | 1988 |
Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension.
Topics: Acebutolol; Adolescent; Antihypertensive Agents; Captopril; Cardiomegaly; Child; Child, Preschool; E | 1986 |
Acebutolol-induced decrease of mononuclear leukocyte beta-adrenoceptors in hypertension.
Topics: Acebutolol; Adult; Blood Pressure; Depression, Chemical; Dihydroalprenolol; Heart Rate; Humans; Hype | 1985 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; | 1987 |
Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
Topics: Acebutolol; Adult; Aged; Aldosterone; Atenolol; Atrial Natriuretic Factor; Cyclic GMP; Female; Human | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolo | 1988 |
[Acebutolol and cerebral blood flow of the moderately hypertensive aged subject].
Topics: Acebutolol; Aged; Cerebrovascular Disorders; Female; Frontal Lobe; Homeostasis; Humans; Hypertension | 1986 |
The interference of acebutolol administration in the measurement of urinary 17-ketosteroid by Zimmermann's method.
Topics: 17-Ketosteroids; Acebutolol; Drug Interactions; Female; Humans; Hypertension; Methods; Middle Aged | 1988 |
Long-term treatment of essential arterial hypertension with nitrendipine.
Topics: Acebutolol; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Mal | 1988 |
[Effects of antihypertensive therapy with acebutolol on plasma lipids].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Cholesterol, HDL; Female; Humans; Hypertension; Male; Middl | 1987 |
The effects of acebutolol alone and in combination with furosemide or hydralazine in experimentally induced hypertensive G-minipigs.
Topics: Acebutolol; Aldosterone; Animals; Drug Therapy, Combination; Female; Furosemide; Heart Rate; Hydrala | 1986 |
[Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
Topics: Acebutolol; Adult; Aged; Cardiovascular Agents; Coronary Disease; Delayed-Action Preparations; Drug | 1987 |
The role of antihypertensive drugs in counteracting adverse influence on large arteries.
Topics: Acebutolol; Antihypertensive Agents; Arteries; Blood Platelets; Calcium; Forearm; Humans; Hypertensi | 1987 |
[A new approach to the evaluation of hypertensive disease].
Topics: Acebutolol; Blood Pressure Determination; Humans; Hypertension; Monitoring, Physiologic; Nifedipine; | 1986 |
[Treatment of light and moderate arterial hypertension with acebutolol].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Bulgaria; Drug Evaluation; Female; France; Humans; Hyperten | 1986 |
To nurse when receiving acebutolol: is it dangerous for the neonate?
Topics: Acebutolol; Breast Feeding; Female; Humans; Hypertension; Infant, Newborn; Milk, Human; Postpartum P | 1986 |
[Sectral].
Topics: Acebutolol; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension | 1985 |
Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese.
Topics: Acebutolol; Antibodies, Antinuclear; Blood Pressure; Eye Diseases; Female; Humans; Hypertension; Jap | 1985 |
[Therapeutic approach to arterial hypertension: comparison and combination of acebutolol with nifedipine and captopril].
Topics: Acebutolol; Captopril; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Mal | 1985 |
The effect of acebutolol on plasma apoproteins and HDL cholesterol subfractions.
Topics: Acebutolol; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Female; Huma | 1985 |
The lowering of daytime blood pressures with a single daily dose of acebutolol in ambulant hypertensives.
Topics: Acebutolol; Adult; Blood Pressure; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged | 1985 |
[Kinetics of the effect of acebutolol in multimorbid geriatric patients].
Topics: Acebutolol; Aged; Female; Humans; Hypertension; Kinetics; Male; Metabolic Clearance Rate | 1985 |